Alzheimer’s Disease and Air Pollution

Pub. date
May 2021
Calderón-Garcidueñas, L.
8 of Advances in Alzheimer's Disease
US$209 / €170 / £153
ISBN print
Environmental Sciences, Neurosciences

Handbook of Traumatic Brain Injury and Neurodegeneration

Pub. date
April 2020
Castellani, R.J.
7 of Advances in Alzheimer's Disease
US$185 / €150 / £135
ISBN print

Differential Diagnosis in Neurology

Pub. date
September 2019
Schwartzman, R.J.
78 of Biomedical and Health Research
US$990 / €850 / £765
ISBN print
Biochemistry, Medicine & Health, Neurosciences

Formal Ontology in Information Systems

Pub. date
September 2018
Borgo, S., Hitzler, P., Kutz, O.
306 of Frontiers in Artificial Intelligence and Applications
US$133 / €108 / £97
ISBN print
Artificial Intelligence, Cognitive Science, Computer Science

Alzheimer’s Disease: New Beginnings

Pub. date
July 2018
Perry, G., Avila, J., Moreira, P.I., Sorensen, A.A., Tabaton, M.
6 of Advances in Alzheimer's Disease
US$234 / €190 / £171
ISBN print

Handbook of Infection and Alzheimer’s Disease

Pub. date
March 2017
Miklossy, J.
5 of Advances in Alzheimer's Disease
US$161 / €140 / £119
ISBN print

Communicating (with) Care

Pub. date
September 2016
Bigi, S.
12 of Emerging Communication: Studies on New Technologies and Practices in Communication
US$115 / €99 / £85
ISBN print
Language Speech, Life & Behavioural Sciences

Handbook of Depression in Alzheimer’s Disease

Pub. date
July 2015
Smith, G.S.
4 of Advances in Alzheimer's Disease
US$155 / €135 / £115
ISBN print

Journal of Alzheimer’s Disease Reports

Journal of Alzheimer's Disease Reports is an open access international multidisciplinary journal to …

US$- / €-
5; 1 issues
Biochemistry, Medicine & Health, Neurosciences

Journal of Medical Psychology

The Journal of Medical Psychology publishes articles (original research, brief reports, and reviews)…

ISSN print
US$173 / €147
23; 2 issues
Biochemistry, Medicine & Health, Neurosciences

Brain Plasticity

Brain Plasticity publishes peer-reviewed Original Articles, Reviews and Short Communications on all…

ISSN print
US$246 / €205
7; 2 issues
Biochemistry, Medicine & Health, Neurosciences

Journal of Neuromuscular Diseases

The Journal of Neuromuscular Diseases aims to facilitate progress in understanding the molecular gen…

ISSN print
US$999 / €792
8; 6 issues
Biochemistry, Medicine & Health, Neurosciences

Journal of Huntington’s Disease

The Journal of Huntington's Disease is an international multidisciplinary journal to facilitate prog…

ISSN print
US$513 / €420
10; 4 issues
Biochemistry, Medicine & Health, Neurosciences, Neurosciences

International Journal of Developmental Science

The International Journal of Developmental Science is especially devoted to research from the fields…

ISSN print
US$272 / €220
15; 4 issues
Biochemistry, Medicine & Health, Life & Behavioural Sciences, Neurosciences, Social Sciences

Journal of Parkinson’s Disease

The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research i…

ISSN print
US$1200 / €1000
11; 4 issues
Biochemistry, Medicine & Health, Neurosciences

Restorative Neurology and Neuroscience

This interdisciplinary journal publishes papers relating to the plasticity and response of the nervo…

ISSN print
US$1573 / €1276
39; 6 issues
Biochemistry, Medicine & Health, Neurosciences


NeuroRehabilitation, an international, interdisciplinary, peer-reviewed journal, publishes manuscrip…

ISSN print
US$1117 / €902
48-49; 8 issues
Biochemistry, Medicine & Health, Neurosciences, Rehabilitation & Assistive Technology

Journal of Vestibular Research

The Journal of Vestibular Research is a peer-reviewed journal that publishes experimental and observ…

ISSN print
US$1122 / €902
31; 6 issues
Biochemistry, Medicine & Health, Neurosciences, Rehabilitation & Assistive Technology

Journal of Alzheimer’s Disease

The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate pro…

ISSN print
US$3280 / €2696
79-84; 24 issues
Biochemistry, Medicine & Health, Neurosciences

Latin American and Caribbean Research: Major Contributions in the Fight Against Alzheimer’s Disease

August 2, 2021 - Amsterdam, NL – Every year there are nearly ten million new cases of dementia globally, of which Alzheimer’s disease (AD) is the most common form, accounting for around 60–70% of cases. This special supplement, published in the Journal of Alzheimer’s Disease, focuses on the challenges posed by brain disease and presents significant research contributions from Latin America and the Caribbean that address these challenges to help improve the lives of individuals with AD.

When We Are Born Can Influence How Mentally Fit We Will Be in Old Age

July 29, 2021 - Prague, Czechia – According to a study published in Journal of Alzheimer's Disease, people born in winter seem to carry a life-long disadvantage in cognitive ageing. Specifically, their cognitive skills are lower when compared to people born in other seasons, even when taking into account other influencing characteristics, such as their education, depression or cardiovascular diseases.

Keystone Bio Advances a More Complete Explanation of Porphyromonas Gingivalis Toxic Virulence Factors

July 27, 2021 - St. Louis, MO, USA – Keystone Bio, a biotechnology company, is a frontrunner in developing precision biologics to eliminate Porphyromonas gingivalis (Pg) and is releasing groundbreaking data that shows bacterial toxic proteins from Pg in the mouth are released into the blood and cross the blood-brain barrier (BBB) as the major driver of sporadic Alzheimer’s disease (AD) and chronic inflammation.

Digital Technology Driving Tangible Advancements in Parkinson’s Disease Research and Clinical Care

July 20, 2021 - Amsterdam, NL – Well over six million people globally have been diagnosed with Parkinson’s disease (PD), which has an enormous impact on the lives of patients, their families, and caregivers and is incurring mounting costs for society. This special supplement to the Journal of Parkinson’s Disease (JPD), guest-edited by noted experts Anat Mirelman, PhD, E. Ray Dorsey, MD, MBA, Patrik Brundin, MD, PhD, and Bastiaan R. Bloem, MD, PhD, reviews how digital technology is being used to reshape research and clinical care in PD.

Autophagy May Be the Key to Finding Treatments for Early Huntington’s Disease

July 15, 2021 - Amsterdam, NL – Huntington’s Disease (HD) is a progressive neurodegenerative condition characterized by motor, cognitive, and psychiatric symptoms, and motor symptoms are often preceded by cognitive changes. Recent evidence indicates that autophagy plays a central role in synaptic maintenance, and the disruption in autophagy may be at the root of these early cognitive changes. Understanding this mechanism better may help researchers develop treatments for patients with HD early in their disease progression, report scientists in a review article published in the Journal of Huntington’s Disease.

Taming the Huntington’s Disease Proteome: Mass Spectrometry May Provide Answers

July 13, 2021 - Mass spectrometry has emerged as an important analytical tool for gaining a better understanding of mechanisms underlying Huntington’s disease (HD), alongside the increased availability of cell and animal models of the disease. This review, published in the Journal of Huntington’s Disease, brings together and recaps data from major published mass spectrometry studies undertaken in HD research over the last 20 years, identifying important changes that occur in HD. The authors encourage researchers to make greater use of these studies to accelerate the development of new treatments.

Digital Pens Provide New Insight into Cognitive Testing Results

July 12, 2021 - Boston, MA, USA – During neuropsychological assessments, participants complete tasks designed to study memory and thinking. Based on their performance, the participants receive a score that researchers use to evaluate how well specific domains of their cognition are functioning. Consider, though, two participants who achieve the same score on one of these paper-and-pencil neuropsychological tests. One took 60 seconds to complete the task and was writing the entire time; the other spent three minutes, and alternated between writing answers and staring off into space. If researchers analyzed only the overall score of these two participants, would they be missing something important?

TV Ads for Prescription Drugs Linked to Higher Utilization Rates Among Seniors

June 22, 2021 - San Francisco, CA, USA – The US is one of the only nations in the world that allows pharmaceutical companies to advertise directly to patients: now, TV ads have been linked with higher utilization rates for certain prescription drugs, especially among older patients. This is according to a study published in the Journal of Alzheimer’s Disease and authored by Professor Robin Feldman of the University of California Hastings College of Law.

Exposure to Air Pollution Increases Risk for Neurodegeneration

June 22, 2021 - Amsterdam, NL – There is growing awareness that air pollutants are playing a critical role in the development of neurodegenerative diseases. A new book, Alzheimer’s Disease and Air Pollution: The Development and Progression of a Fatal Disease from Childhood and the Opportunities for Early Intervention, edited by Lilian Calderón-Garcidueñas, MD, PhD, compiles the latest research establishing links between air pollution and neurodegeneration. It is part of the Advances in Alzheimer’s Disease series, published by IOS Press.

Depression, Tau Deposits Seen in Subset of Middle-Aged Persons

June 18, 2021 - San Antonio, TX, USA – Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain’s emotion- and memory-controlling regions, a new study by researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and collaborating institutions suggests. The Journal of Alzheimer’s Disease will publish the findings in its June 29, 2021 issue.

Treatabolome Project Designed to Shorten Diagnosis-to-Treatment Time for Patients with Rare Diseases

June 1, 2021 - Amsterdam, NL – The Treatabolome project is a research initiative to develop a freely available, interoperable online platform dedicated to disseminating rare disease and gene-specific treatment information to healthcare professionals regardless of their level of specialized expertise. Developed under the Solve-RD European Research Project, it is intended to reduce treatment delays for patients with rare diseases by directly linking diagnosis and treatment information. This initiative is highly relevant to neuromuscular disorders as they are rare diseases by definition. In this special issue of the Journal of Neuromuscular Diseases, experts contribute Treatabolome-feeding systematic literature reviews on rare neurological and neuromuscular disorders.

Meditative Practice and Spiritual Wellbeing May Preserve Cognitive Function in Aging

May 11, 2021 - Amsterdam, NL – It is projected that up to 152 million people worldwide will be living with Alzheimer’s disease (AD) by 2050. To date there are no drugs that have a substantial positive impact on either the prevention or reversal of cognitive decline. A growing body of evidence finds that targeting lifestyle and vascular risk factors have a beneficial effect on overall cognitive performance. A new review in the new review in the Journal of Alzheimer’s Disease, published by IOS Press, examines research that finds spiritual fitness, a new concept in medicine that centers on psychological and spiritual wellbeing, and Kirtan Kriya, a simple 12-minute meditative practice, may reduce multiple risk factors for AD.

COVID-19 Lockdown Increases Depression in Patients with Alzheimer’s Disease: Is This Backed by Research?

May 10, 2021 - Nantes, France – The lockdown, as implemented to cope with the COVID-19 pandemic, has drastically changed our everyday lives. Patients with Alzheimer’s disease (AD), especially those who live in retirement homes, are not indifferent to the dramatic impact of the lockdown on social interactions.

New Study Reveals an Association Between the Presence of Certain Infections and Later Development of Alzheimer’s Disease

May 10, 2021 - Montreal, QC, Canada – A large-scale population-based study led by Paul Brassard, MD, of the Lady Davis Institute at the Jewish General Hospital, discovered that there is an association between infectious disease burden and the risk of Alzheimer’s disease (AD). The results are published in the Journal of Alzheimer’s Disease.

International Task Force Determines Current Parkinson’s Disease Subtyping May Not Fit All Patients

April 29, 2021 - Amsterdam, NL – The clinical presentation and underlying biology of Parkinson’s disease (PD) varies significantly, but attempts to cluster cases into a limited number of subtypes have questionable applicability and relevance, reports the international Task Force for PD Subtypes in the Journal of Parkinson’s Disease. Their systematic review of studies reporting a subtyping system for the first time concludes that new approaches are needed that acknowledge the individual nature of the disease and are more aligned with personalized medicine.

New Model May Explain the Mystery of Asymmetry in Parkinson’s Disease

April 28, 2021 - Amsterdam, NL – Parkinson’s disease (PD) is characterized by slowness of movement and tremors, which often appear asymmetrically in patients. The new model of PD described in this review article published in the Journal of Parkinson’s Disease may explain these perplexing asymmetrical motor symptoms and other known variations such as different degrees of constipation and sleep disorders.

The Greener the Neighborhood, the Lower Risk of Alzheimer’s Disease and Dementias

April 27, 2021 - Miami, FL, USA – A new University of Miami Miller School of Medicine-led study examined the relationship of neighborhood greenness, such as trees, shrubs, or grass, to Alzheimer’s disease, Non-Alzheimer’s dementia, and Alzheimer’s disease and related dementia. The study – published online on April 1, 2021 in the Journal of Alzheimer’s Disease – found that a greater presence of neighborhood greenness was associated with a lower prevalence of Alzheimer’s disease by 20% and non-Alzheimer's disease by 11%.

Chronic Pain and Other Life Experiences May Contribute to Brain Matter Loss

April 27, 2021 - Gainesville, FL, USA – A new University of Florida study of non-Hispanic Black and non-Hispanic white adults links, published in the Journal of Alzheimer's Disease, chronic knee pain and key demographic factors to differences in areas of the brain tied to memory. Participants who reported higher stages of pain and lower levels of income and education and less access to health insurance had thinner gray matter in these regions than those also experiencing higher stages of pain but who reported higher levels of income, education and greater access to health insurance.

Which Parkinson’s Symptoms Do Patients Most Want to See Improved by Treatment?

April 26, 2021 - Amsterdam, NL – Individuals with Parkinson’s disease (PD) face a wide range of symptoms and challenges. A team from Parkinson’s UK, including several Patient and Public Involvement (PPI) contributors, surveyed patients to find out which PD symptoms troubled them most and how priorities may change with condition duration. Their goal was to identify where improved treatments and strategies are most needed to help maintain independence and quality of life. They report their findings in the Journal of Parkinson’s Disease.

Aluminum Is Intricately Associated with the Neuropathology of Familial Alzheimer’s Disease

April 9, 2021 - Keele, UK – A new study published in the Journal of Alzheimer’s Disease Reports continues to support a growing body of evidence that aluminum contributes to the pathogenesis of Alzheimer’s disease (AD). Researchers found aluminum co-located with phosphorylated tau protein, which is an early initiator of AD. This study builds upon two earlier published studies (including Mold et al., 2020, Journal of Alzheimer’s Disease) from the same group.

New Study Expands Evaluation of Gene Therapy for Spinal Muscular Atrophy

April 6, 2021 - Amsterdam, NL – The rarity of spinal muscular atrophy (SMA) means that promising new treatments may be tested in only a limited spectrum of patients before approval. Investigators evaluated a newly approved drug, onasemnogene abeparvovec, in a broader spectrum of patients in order to obtain expanded data on its side effects profile. They report in the Journal of Neuromuscular Diseases that the drug is associated with an immune response against the adeno-associated viral vector and needs careful monitoring, but showed no long-term adverse effects.

Dementia and COVID: What Families and Physicians Should Know

April 5, 2021 - New York, NY, USA – Early in the pandemic, neurologists expressed concern that COVID-19 patients with dementia may be at higher risk for complications and mortality. But those fears have not been realized, according to a new study of patients who were hospitalized with COVID-19 during the first wave of the pandemic in New York City. The study, led by James Noble, MD, MS, associate professor of neurology at Columbia University Vagelos College of Physicians and Surgeons and the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, and Amro Harb, a Vagelos medical student, has been published online in the Journal of Alzheimer’s Disease.

Dementia Death Risk is Higher Among the Socioeconomically Deprived

March 31, 2021 - London, UK – A large proportion of dementia deaths in England and Wales may be due to socioeconomic deprivation, according to new research led by Queen Mary University of London. The team also found that socioeconomic deprivation was associated with younger age at death with dementia, and poorer access to accurate diagnosis. Dementia is the leading cause of death in England and Wales, even during the COVID-19 pandemic, and is the only disease in the top ten causes of death without effective treatment.

The Important Role of Music in Neurorehabilitation: Filling in Critical Gaps

March 10, 2021 - Amsterdam, NL – Music-based interventions have become a core ingredient of effective neurorehabilitation in the past 20 years thanks to the growing body of knowledge. In this theme issue of Neurorehabilitation, experts in the field highlight some of the current critical gaps in clinical applications that have been less thoroughly investigated, such as post-stroke cognition, traumatic brain injury, and autism and specific learning disabilities.

Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic

March 2, 2021 - Navarra, Spain – While the media have been in charge of alerting of the serious situation in nursing care homes and hospitals, people with dementia who lived at home as well as their caregivers, have suffered the consequences of mandatory household confinement in silence. The study, led by the “Dementia Group” of “Navarra Society of Geriatrics and Gerontology” in collaboration with Geriatric’s Service of the “Hospital de Navarra” and “Alzheimer’s Family Association in Navarra” (AFAN), has been published in the Journal of Alzheimer’s Disease. A multi-tiered supportive approach that ensures the continuity of a quality care for people with dementia and their caregivers must be developed. New technologies adapted to the current pandemic situation are being developing.

New Research Finds Exercise May Help Slow Memory Loss for People Living with Alzheimer’s Dementia

February 26, 2021 - Phoenix, Arizona, USA – Promising new research shows aerobic exercise may help slow memory loss for older adults living with Alzheimer’s dementia. ASU Edson College of Nursing and Health Innovation Professor Fang Yu led a pilot randomized control trial that included 96 older adults living with mild to moderate Alzheimer’s dementia. Participants were randomized to either a cycling (stationary bike) or stretching intervention for six months.

Researchers Find New Way to Diagnose Potential for Alzheimer’s Disease

February 24, 2021 - Memphis, TN, USA – Early diagnosis of Alzheimer’s disease has been shown to reduce cost and improve patient outcomes, but current diagnostic approaches can be invasive and costly. A recent study, published in the Journal of Alzheimer’s Disease, has found a novel way to identify a high potential for developing Alzheimer’s disease before symptoms occur. Ray Romano, PhD, RN, completed the research as part of his PhD in the Nursing Science Program at the University of Tennessee Health Science Center (UTHSC) College of Graduate Health Sciences. Dr. Romano conducted the research through the joint laboratory of Associate Professor Todd Monroe, PhD, RN, at The Ohio State University, who is also a graduate of the UTHSC Nursing Science PhD Program and Ronald Cowan, MD, PhD, who is the Chair of Psychiatry at UTHSC.

Spinal Fluid of People with Alzheimer’s Risk Gene Signals Inflammation

February 16, 2021 - Durham, NC, USA – People who have a gene variant associated with an increased risk of developing Alzheimer’s disease also tend to have changes in the fluid around their brain and spinal cord that are detectable years before symptoms arise, according to new research from Duke Health. The work found that in people who carry the APOE4 gene variant, which is found in roughly 25 percent of the population, the cerebrospinal fluid contains lower levels of certain inflammatory molecules. This raises the possibility that these inflammatory molecules may be collecting in the brain where they may be damaging synapses, rather than floating freely in the cerebrospinal fluid.

Insights into the Role of DNA Repair and Huntington’s Disease Gene Mutation Open New Avenues for Drug Discovery

February 11, 2021 - Amsterdam, NL – Recent genetic data from patients with Huntington’s disease (HD) show that DNA repair is an important factor that determines how early or late the disease occurs in individuals who carry the expanded CAG repeat in the HTT gene that causes HD. The processes of DNA repair further expand the CAG repeats in HTT in the brain implicated in pathogenesis and disease progression. This special issue of the Journal of Huntington’s Disease (JHD) is a compendium of new reviews on topics ranging from the discovery of somatic CAG repeat expansion in HD, to our current understanding of the molecular mechanisms involved and the development of potential new therapies targeting these mechanisms.

Adult Neurogenesis May Hold Clues for More Effective Treatment of Alcoholism

February 10, 2021 - Amsterdam, NL – Neuroplasticity, the remarkable ability of the brain to modify and reorganize itself, is affected by or in response to excessive alcohol, whether through individual consumption or exposure in the womb. It is now well accepted that the birth and integration of new neurons continue beyond development and into adulthood. New discoveries and insights on how alcohol impacts this and other plastic processes are discussed in Alcohol and Neural Plasticity, a special issue of Brain Plasticity.

Research Establishes a New Method to Predict Individual Risk of Cognitive Decline

February 9, 2021 - Lexington, KY, USA – The early prognosis of high-risk older adults for amnestic mild cognitive impairment (aMCI), using noninvasive and sensitive neuromarkers, is key for early prevention of Alzheimer’s disease. A recent study, published in the Journal of Alzheimer’s Disease, by researchers at the University of Kentucky establishes what they believe is a new way to predict the risk years before a clinical diagnosis. Their work shows that direct measures of brain signatures during mental activity are more sensitive and accurate predictors of memory decline than current standard behavioral testing.

Air Pollution Poses Risk to Thinking Skills in Later Life, a Study Says

February 8, 2021 - Edinburgh, UK – Exposure to air pollution in childhood is linked to a decline in thinking skills in later life, a study published in the Journal of Alzheimer's Disease suggests. A greater exposure to air pollution at the very start of life was associated with a detrimental effect on people’s cognitive skills up to 60 years later, the research found.

Psychological Distress of Lockdown in Pre-Dementia Patients Prolonged During the COVID-19 De-Escalation

February 3, 2021 - Barcelona, Spain – The effects of the lockdown decreed to deal with the COVID-19 pandemic on the mental health of elderly people in pre-dementia stages were protracted during the de-escalation phase. This is highlighted by an open access study published in the Journal of Alzheimer's Disease, led by researchers from the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar, as well as researchers from the CIBER on the Physiopathology of Obesity and Nutrition (CIBEROBN) and the CIBER on Fragility and Healthy Ageing (CIBERFES). The work was carried out in collaboration with the Barcelona βeta Brain Research Center (BBRC).

COVID-19 Vaccination for Patients with Parkinson’s Disease Recommended

February 3, 2021 - Amsterdam, NL – Patients with Parkinson’s disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine’s efficacy and safety in the specific context of PD and its symptomatic treatment. In a commentary just published in the Journal of Parkinson’s Disease, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with PD, unless there is a specific contraindication.

Dementia Rates Higher in Men with Common Genetic Disorder Haemochromatosis

February 2, 2021 - Exeter, UK – Researchers at the University of Exeter and the University of Connecticut have previously found that men with two faulty genes that cause the iron overload condition haemochromatosis are more likely to develop liver cancer, arthritis and frailty, compared to those without the faulty genes. Now, the team’s new analysis of more than 335,000 people of European ancestry in UK Biobank, funded by the Medical Research Council and published as an open access study in the Journal of Alzheimer’s Disease, has found that men who carry the two faulty genes that cause haemochromatosis are more likely to develop dementia than men who do not carry any copies of the faulty gene.

Neuromuscular Disease Registry Helps Patients Access Research, Clinical Trials, New Genetic Tests, and Therapies

February 2, 2021 - Amsterdam, NL– The Canadian Neuromuscular Disease Registry (CNDR) was launched in 2010 to increase efficient patient access to cutting-edge research and clinical trials, to increase understanding of the natural history and epidemiology of neuromuscular disease across Canada, and to facilitate research collaboration. An assessment of CNDR’s accomplishments, published in the Journal of Neuromuscular Diseases, found that it has been successful in securing funding and engaging the community over the past 10 years. With more than 4,000 enrolled patients, data from the registry have been used in over 125 research projects as of 2019, including clinical trial and research notifications, patient questionnaires, and data analyses around patient outcomes and care.

Obesity May Exacerbate the Effects of Alzheimer’s Disease, New Study Shows

February 1, 2021 - Sheffield, UK – New research from the University of Sheffield has found being overweight is an additional burden on brain health and it may exacerbate Alzheimer’s disease. The pioneering multimodal neuroimaging study revealed obesity may contribute toward neural tissue vulnerability, whilst maintaining a healthy weight in mild Alzheimer’s disease dementia could help to preserve brain structure. The findings, published in the Journal of Alzheimer’s Disease Reports, also highlight the impact being overweight in mid-life could have on brain health in older age.

An Integrated Approach for an Effective Prevention of Alzheimer’s Disease

January 29, 2021 - Santiago, Chile – This new pioneering study by Prof. Ricardo Maccioni and coworkers of the International Center for Biomedicine, “New Frontiers in the prevention, diagnosis and treatment of Alzheimer's disease” will be published in an upcoming special issue featuring Latin American investigators of the Journal of Alzheimer’s Disease.

Over Half of Cannabis Users with Parkinson’s Disease Report Clinical Benefits

January 26, 2021 - Amsterdam, NL – With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson’s disease (PD). According to results of a survey of PD patients in Germany in the Journal of Parkinson’s Disease, over 8% of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect.

New Study Shows the Relationship Between Surgery and Alzheimer’s Disease

January 21, 2021 - Sandander, Spain – A new study published in the Journal of Alzheimer’s Disease carried out by researchers at the Marqués de Valdecilla-IDIVAL University Hospital, in collaboration with researchers at the University of Bonn Medical Center, proposes that major surgery is a promoter or accelerator of Alzheimer's disease (AD). The first author of the publication was Carmen Lage and the principal investigator Pascual Sánchez-Juan.

Study Suggests That Gut Fungi Are Not Associated With Parkinson’s Disease

January 21, 2021 - Amsterdam, NL – The bacterial gut microbiome is strongly associated with Parkinson’s disease (PD), but no studies had previously investigated the role of fungi in the gut. In this novel study published in the Journal of Parkinson’s Disease, a team of investigators at the University of British Columbia examined whether the fungal constituents of the gut microbiome are associated with PD. Their research indicated that gut fungi are not a contributing factor, thereby refuting the need for any potential anti-fungal treatments of the gut in PD patients.

Approximately Half of Alzheimer’s Disease Dementia Cases are Mild, One-Fifth are Severe

January 14, 2021 - Boston, MA, USA – What percent of patients with Alzheimer’s disease (AD) currently have severe dementia? Do more people have mild disease? Or are the majority suffering with moderate dementia? A new study published in the Journal of Alzheimer’s Disease using data from the Framingham Heart Study (FHS) sheds light on these trends.

New Evidence: Effects of Huntington’s Disease Mutation May Begin in Childhood

January 6, 2021 - Amsterdam, NL – There is growing evidence to support the hypothesis that there is a neurodevelopmental component to the late-onset neurodegeneration occurring in the brain of huntingtin gene (HTT gene) mutation carriers, and that this increased susceptibility to brain cell death begins during childhood. Experts discuss the evidence that the HTT gene mutation affects brain and body growth based on a unique study of children at risk for HD, the Kids-HD study, in a review paper and accompanying research article published in the Journal of Huntington’s Disease.

New Study Suggests Diet Modifications – Including More Wine and Cheese – May Help Reduce Cognitive Decline

December 18, 2020 - Ames, IA, USA – The foods we eat may have a direct impact on our cognitive acuity in our later years. This is the key finding of an Iowa State University research study spotlighted in an article published in the Journal of Alzheimer’s Disease. The study was spearheaded by principal investigator, Auriel Willette, an assistant professor in Food Science and Human Nutrition, and Brandon Klinedinst, a Neuroscience PhD candidate working in the Food Science and Human Nutrition department at Iowa State. The study is a first-of-its-kind large scale analysis that connects specific foods to later-in-life cognitive acuity.

Caregiver Burden in Dementia During the COVID-19 Crisis

December 10, 2020 - Athens and Patras, Greece – Caregivers of people with dementia and milder forms of neurocognitive disorder bear a heavy burden. They are constantly confronted with challenging symptoms and behaviors and feel they are up against their limits. The latest results from a study published in the Journal of Alzheimer's Disease indicate that the COVID-19 crisis affects this burden since the pandemic has mental health implications.

Link Between Alzheimer’s Disease and Gut Microbiota is Confirmed

November 25, 2020 - Brescia, Italy – Alzheimer's disease is the most common cause of dementia. Still incurable, it directly affects nearly one million people in Europe, and indirectly millions of family members as well as society as a whole. In recent years, the scientific community has suspected that the gut microbiota plays a role in the development of the disease. A team from the University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG) in Switzerland, together with Italian colleagues from the National Research and Care Center for Alzheimer's and Psychiatric Diseases Fatebenefratelli in Brescia, University of Naples and the IRCCS SDN Research Center in Naples, confirm the correlation, in humans, between an imbalance in the gut microbiota and the development of amyloid plaques in the brain, which are at the origin of the neurodegenerative disorders characteristic of Alzheimer's disease.

Neurorehabilitation Experts Highlight Breakthroughs in Neurogenic Pain Management

November 18, 2020 - Amsterdam, NL – There have been significant advances in knowledge regarding the pathology, etiology, assessment, and treatment of several significant neurogenic pain disorders regularly encountered by neurorehabilitation professionals in both inpatient and outpatient care. In a collection of articles published in NeuroRehabilitation, experts describe the latest advancements in neurogenic classification and pain management and treatment of these disorders.

New Study Finds a Link Between Sleep Apnea and Increased Risk of Dementia

November 11, 2020 - Melbourne, Australia – A new study by Monash University has found that obstructive sleep apnea (OSA) has been linked to an increased risk of dementia. The study, published in the Journal of Alzheimer’s Disease, and led by Dr. Melinda Jackson from the Turner Institute for Brain and Mental Health, found that severe OSA is linked to an increase in a protein, called beta-amyloid, that builds up on the walls of the arteries in the brain and increases the risk of dementia.

Psychological Status Rather Than Cognitive Status is Associated with Incorrect Perception of Risk of Falling in Patients with Moderate Stage Dementia

November 10, 2020 - Heidelberg, Germany – Dementia is associated with an impaired self-perception with potentially harmful consequences for health status and clinical risk classification in this patient group with an extraordinary high risk of falling. A new study published in the Journal of Alzheimer’s Disease indicates that psychological factors such as anxiety or fear of falling, cognitive sub-performances such as executive functions, as well as behavioral strategies such as support seeking and interplay with other risk factors should be considered when risk of falling is documented in patients with dementia (PWD).

A Randomized Clinical Trial of Greek High Phenolic Early Harvest Extra Virgin Olive Oil in Mild Cognitive Impairment: the MICOIL Pilot Study

November 9, 2020 - Thessaloniki, Greece – Greek researchers and clinicians investigated for the first time the effect of High Phenolic Early Harvest Extra Virgin Olive Oil (HP-EH-EVOO) versus Moderate Phenolic (MP-EVOO) and Mediterranean Diet (MeDi) as a therapeutic pharmaceutical natural compound for older adults with amnestic Mild Cognitive Impairment (aMCI). Amnestic MCI is usually a prodromal condition of Alzheimer’s disease (AD) and is characterized by memory loss and inability to execute very complex Activities of Daily Living. While there is no treatment for MCI and symptomatic only treatment for AD, the global effort against cognitive disorders is focused on early detection and management of AD at the stage of aMCI.

New Vaccine Targeting Toxic Amyloid-β Could Help Halt Alzheimer’s Disease Progression, Preclinical Study Finds

November 3, 2020 - Tampa, FL, USA – Our immune system’s capacity to mount a well-regulated defense against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65. At the same time, research has shown that immunotherapy targeting neurotoxic forms of the peptide amyloid beta (oligomeric Aβ) may halt the progression of Alzheimer’s disease, the most common age-related neurodegenerative disease.

Brain Stimulation Improves Condition of Patients with Alzheimer’s

October 15, 2020 - Boston, MA, USA – A VA pilot study finds that a brain stimulation therapy provided to patients with Alzheimer’s disease improved their state of apathy, a profound loss of motivation and initiative and a feeling of social withdrawal. Apathy is the most common behavioral problem in people with Alzheimer’s disease, the primary form of dementia. The results appeared online in the Journal of Alzheimer's Disease on October 13, 2020.

Older People with Early, Asymptomatic Alzheimer’s at Risk of Falls

October 14, 2020 - St. Louis, MO, USA – Falls are the leading cause of fatal injuries in older adults, causing more than 800,000 hospitalizations and about 30,000 deaths in the US every year. Some risk factors are well-known – advanced age, problems with vision or balance, muscle weakness – but an under-recognized factor is early Alzheimer’s disease. Older people in the earliest stages of Alzheimer’s, before cognitive problems arise, are more likely to suffer a fall than people who are not on track to develop dementia.

Poor Cognitive Performance Predicts Impairment in Activities of Daily Living Years Later

October 1, 2020 - San Diego, CA, USA – Subtle differences in cognition may help identify individuals at risk for becoming dependent years later upon others to complete daily activities, such as managing medications or finances and other essential activities.

Persons with Parkinson’s Disease Can Have a Brighter Future

September 23, 2020 - Amsterdam, NL – Well over six million people globally have been diagnosed with Parkinson's disease, which has an enormous impact on the lives of patients and their families and incurring mounting costs for society. In this special supplement to the Journal of Parkinson's Disease experts review common and vexing issues affecting people with Parkinson's disease as well as emerging concerns such as the importance of personalized care management.

Neurological Consequences of COVID-19: The “Silent Wave”

September 22, 2020 - Mebourne, Australia – Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health. A team of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve.

Awareness of COVID-19 in Severe Dementia Patients

September 21, 2020 - Tokyo, Japan – The ongoing coronavirus disease 2019 (COVID-19) pandemic has substantially affected patients with dementia and their caregivers. Owing to the restrictive measures taken worldwide to block the spread of COVID-19 outbreaks (including the declaration of a state of emergency in Japan), patients with dementia and their caregivers have not been able to receive the usual support and care. Therefore, this is expected to lead to adverse effects on the patients and their caregivers, and many investigators have warned about the risks [1–3]. In fact, many scheduled appointments for routine outpatients’ examinations and care services have been canceled and postponed owing to the COVID-19 outbreak.

The CABLE Study: Green Tea Consumption May Help Fend Off Cognitive Decline by Affecting Alzheimer’s Disease Tau Pathology

September 17, 2020 - Shanghai, China – A team from the Qingdao University and Fudan University of China recruits more than 700 older adults aged 40 years or older, investigates their drinking tea habits, and assesses their cognitive function and especially alterations of aging brain pathology, i.e., Alzheimer’s disease (AD).

Estrogen Replacement May Protect Against Alzheimer’s Disease in Women

September 1, 2020 - Amsterdam, NL – Alzheimer's disease (AD) is the most common neurodegenerative disease and the leading cause of dementia. It affects more women than men. A new study published in the Journal of Alzheimer’s Disease indicates that factors such as age, reproductive stage, hormone levels, and the interplay with other risk factors should be considered in women and proposes a role for early menopausal estrogen replacement to protect against the development of AD.

Stress Overload and Pain Common Among Patients with Traumatic Brain Injury

August 18, 2020 - Amsterdam, NL – Traumatic brain injury (TBI) is a leading cause of death and disability. Post-injury distress is common, with many individuals experiencing chronic anxiety and depressive symptoms as well as chronic pain. In this collection of articles in the journal NeuroRehabilitation, experts report on findings that shed light on the relationship between stress and pain following a TBI and implications for rehabilitation.

Body Weight Has Surprising, Alarming Impact on Brain Function

August 5, 2020 - Amsterdam, NL and Costa Mesa, CA, USA – As a person's weight goes up, all regions of the brain go down in activity and blood flow, according to a new brain imaging study in the Journal of Alzheimer's Disease. One of the largest studies linking obesity with brain dysfunction, scientists analyzed over 35,000 functional neuroimaging scans using single-photon emission computerized tomography from more than 17,000 individuals to measure blood flow and brain activity.

The Outlook Is Encouraging: Researchers Evaluate a Pipeline of Clinical Trials Targeting Parkinson’s Disease

August 3, 2020 - Amsterdam, NL – A review of currently registered clinical trials of agents targeting Parkinson's disease (PD) reveals that there is a broad pipeline of both symptomatic and potentially disease-modifying therapies currently being evaluated. Investigators report that the outlook for patients is encouraging, given the wide range of therapeutics being clinically tested. They emphasize the importance of engaging the Parkinson's community in the research. Their analysis and results are published in the Journal of Parkinson's Disease.

Memory Loss Reversed or Abated in those with Cognitive Decline

July 31, 2020 - Sonoma, CA, USA – Affirmativ Health sought to determine whether a comprehensive and personalized program, designed to mitigate risk factors of Alzheimer's disease could improve cognitive and metabolic function in individuals experiencing cognitive decline. Findings published in the Journal of Alzheimer's Disease Reports provided evidence that this approach can improve risk factor scores and stabilize cognitive function.

Journal of Parkinson’s Disease Awards First Parkinson Prizes

July 22, 2020 - Amsterdam, NL – The Journal of Parkinson's Disease and its publisher IOS Press are proud to announce the two articles that have won the first Parkinson Prize, recognizing these outstanding contributions to the advancement to Parkinson's disease research. Recipients of the award are lead investigator Thomas Foltynie, MD, PhD (research article) and co-authors Heiko Braak, MD, and Kelly Del Tredici, MD, PhD (review article).

Hospital Improves On-Time Administration of Medication to Parkinson Patients

July 9, 2020 - Amsterdam, NL – Timely administration of anti-Parkinson drugs is a significant issue for hospitalized patients with Parkinson’s disease (PD) with late or missed doses resulting in longer stays and worse outcomes. As part of a quality improvement project, a multidisciplinary team was able to change the culture at a US hospital by using a series of measures to ensure PD patients receive medications on time. Their findings are published in the Journal of Parkinson's Disease.

Christin Nance and Sarah Banks Receive 2020 Alzheimer Award

July 8, 2020 - Amsterdam, NL – The Journal of Alzheimer's Disease (JAD) is pleased to announce that the joint recipients of the 2020 Alzheimer Award are Christin Nance, BA, and Sarah Banks, PhD.

Journal of Parkinson’s Disease Achieves Significant Impact Factor Increase

July 7, 2020 - Amsterdam, NL – The Journal of Parkinson's Disease (JPD) and its publisher IOS Press are proud to announce that JPD's Journal Impact Factor has increased to 5.178 according to Clarivate's 2020 edition of the Web of Science Journal Citation Reports (JCR). This represents an impressive 40% increase from last year.

How Upregulation of a Single Gene by SARS-CoV-2 Can Result in a Cytokine Storm

June 29, 2020 - Amsterdam NL – The SARS-CoV-19 virus initially has a limited capability to invade, attacking only one intracellular genetic target, the aryl hydrocarbon receptors (AhRs). Yet it leads to widely diverse clinical symptoms, suggesting multiple pathogenic mechanisms. Writing in Restorative Neurology and Neuroscience, investigators describe how excessive activation of AhRs via the IDO1-kynurenine-AhR signaling pathway, which is used by many pathogens to establish infection, leads to “Systemic AhR Activation Syndrome” (SAAS). The authors also hypothesize that therapies targeting downregulation of AhRs and IDO1 genes should decrease severity of infection.

Treat Early or Wait? Experts Ponder Best Way to Manage Milder Forms of Spinal Muscular Atrophy

June 11, 2020 - Amsterdam, NL – The advent of therapeutic interventions for spinal muscular atrophy (SMA) has increased the importance of presymptomatic diagnosis and treatment. When to start treatment in children with less severe disease remains controversial. Now, in a report published in the Journal of Neuromuscular Diseases, German researchers argue for an earlier start of treatment to prevent permanent nerve damage, challenging recommendations originally proposed by a group of American experts that suggests a strict follow-up strategy for children expected to have less severe disease.

Growth Factors and Parkinson’s Disease – Where Next?

June 4, 2020 - Amsterdam, NL – Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson’s disease (PD), but trials have been disappointing. A panel of prominent leaders in the field convened to discuss whether there is a future for this approach and what any future PD trial involving GDNF and other GDNF family neurotrophic factors should consider. Their discussions and recommendations are published in the Journal of Parkinson's Disease.

COVID-19 May Compound the Social and Economic Burdens of Parkinson’s Disease

May 12, 2020 - Amsterdam, NL – Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD. Writing in the Journal of Parkinson's Disease (JPD), scientists discuss several avenues through which the COVID-19 pandemic might contribute to the expected exponential growth of PD in the coming years, compounding the economic and societal impacts of the disease.

New Trial Platform Could Accelerate Finding a Cure for Parkinson’s Disease

May 6, 2020 - Amsterdam, NL – Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease (PD). In the Journal of Parkinson's Disease scientists report on the possibility of using a multi-arm, multi-stage trial platform to evaluate several potential therapies at once, using lessons learned from other diseases.

New Evidence that Higher Caffeine and Urate Levels Are Protective Against Parkinson’s Disease

May 5, 2020 - Amsterdam, NL – Two purines, caffeine and urate, have been associated with a reduced risk of Parkinson's disease (PD) in multiple study groups and populations. Analysis of data from the Harvard Biomarkers Study shows that lower levels of caffeine consumption and lower blood urate are inversely associated with PD, strengthening the links between caffeine intake and urate levels and PD, reports a study in the Journal of Parkinson's Disease (JPD).

Exercise Reduces Caregiver’s Burden in Dementia Care

April 9, 2020 - Cologne, Germany – Exercise in older adults, even at an advanced stage of dementia, is an important strategy to maintain independence in everyday living and to promote quality of life. The research group "geriatric psychiatry in motion" of the German Sport University Cologne and the LVR-Hospital Cologne develop and evaluate exercise programs for geriatric mental health care. Latest results from a study in acute dementia care indicate a special exercise program is not only effective for the patients themselves, but also reduces the professional caregiver’s burden caused by neuropsychiatric symptoms.

Neuropsychological and Psychological Methods Are Essential Components of the Neurorehabilitative Process

April 8, 2020 - Amsterdam, NL – Clinical neuropsychology and psychology have evolved as diagnostic and treatment-oriented disciplines necessary for individuals with neurological, psychiatric, and medical conditions. In this collection of articles in the journal NeuroRehabilitation experts highlight medical advances in neuropsychological and psychological applications in neurorehabilitation.

Patients with Parkinson’s Disease Face Unique “Hidden Sorrows” Related to the COVID-19 Pandemic

April 3, 2020 - Amsterdam, NL – While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson’s disease (PD), the impact extends beyond these threats. Social distancing requires flexible adaptation to new circumstances, resilience, and a reduction in physical activities, which may be more difficult for patients with PD.

Can Lithium Halt Progression of Alzheimer’s Disease?

February 14, 2020 - Montreal, Canada – There remains a controversy in scientific circles today regarding the value of lithium therapy in treating Alzheimer’s disease. Much of this stems from the fact that because the information gathered to date has been obtained using a multitude of differential approaches, conditions, formulations, timing and dosages of treatment, results are difficult to compare. In addition, continued treatments with high dosage of lithium render a number of serious adverse effects making this approach impracticable for long term treatments especially in the elderly.

Simple Blood Test Could Help Predict Progression of Parkinson’s Disease

February 12, 2020 - Amsterdam, NL – In order to provide the best medical care for newly diagnosed Parkinson's disease (PD) patients, a method of predicting their cognitive and motor progression, beyond using purely clinical parameters, would have major implications for their management. A novel study published in the Journal of Parkinson’s Disease suggests that a blood test for inflammatory and cell senescence biomarkers may be a reliable predictor of cognitive decline, including identifying those who will develop an early dementia and motor progression in PD patients.

Long-Distance Skiers May Have “Motor Reserve” that Can Delay Onset of Parkinson’s Disease

February 11, 2020 - Amsterdam, NL – To better understand the relationship between physical activity and Parkinson's disease (PD) investigators in Sweden analyzed medical records of nearly 200,000 long-distance skiers who took part in the Vasaloppet cross-country ski race. They established that a physically active lifestyle is associated with close to a 30% reduced risk for PD, which might be explained by a motor reserve among the physically active, however, this dissipates as individuals age. Their results are published in the Journal of Parkinson's Disease (JPD).

Aerobic Exercise Training Linked to Enhanced Brain Function in Adults at Risk for Alzheimer’s Disease

February 3, 2020 - Amsterdam, NL – Individuals at risk for Alzheimer's disease (AD) because of family history or genetic predisposition who engaged in six months of aerobic exercise training improved their brain glucose metabolism and higher-order thinking abilities (e.g., planning and mental flexibility) called executive function; these improvements occurred in conjunction with increased cardiorespiratory fitness. The results of this study are published in a special issue of Brain Plasticity devoted to Exercise and Cognition.

High and Low Exercise Intensity Found to Influence Brain Function Differently

January 30, 2020 - Amsterdam, NL – A new study shows for the first time that low and high exercise intensities differentially influence brain function. Using resting state functional magnetic resonance imaging (Rs-fMRI), a noninvasive technique that allows for studies on brain connectivity, researchers discovered that low-intensity exercise triggers brain networks involved in cognition control and attention processing, while high-intensity exercise primarily activates networks involved in affective/emotion processing. The results appear in a special issue of Brain Plasticity devoted to Exercise and Cognition.

Mild Cognitive Impairment: ISS Produces the First Epidemiological Estimation of the Phenomenon Among Migrants in Europe

January 30, 2020 - Rome, Italy – In a study published in the Journal of Alzheimer's Disease, researchers from Italy’s Istituto Superiore di Sanità (ISS) (National Institute of Health) estimated about 680,000 cases of mild cognitive impairment (MCI), in a total of 12,730,960 migrants, aged between 60 and 89 years, living in the European Union (EU) in 2018.

Light at the End of the Tunnel for Most Individuals With Low-Vision

January 22, 2020 - Amsterdam, NL – Progress in research and technology is giving rise to an optimistic future for compensation and restoration of low vision, according to research in a special issue of Restorative Neurology and Neuroscience, published by IOS Press. Seven studies explore different aspects of vision loss after damage to the retina, optic nerve or brain due to diseases such as glaucoma or optic neuropathy. Remarkable progress is being made to treat conditions of partial blindness that have previously been considered irreversible.

Human Exposure to Aluminum Linked to Familial Alzheimer’s Disease

January 20, 2020 - Amsterdam, NL – A new study published in the Journal of Alzheimer's Disease (JAD) supports a growing body of research that links human exposure to aluminum with Alzheimer's disease (AD). Researchers found significant amounts of aluminum content in brain tissue from donors with familial AD. The study also found a high degree of co-location with the amyloid-beta protein, which leads to early onset of the disease.

Progress in Unraveling the Mystery of the Genomics of Parkinson’s Disease

January 16, 2020 - Amsterdam, NL – The International Parkinson Disease Genomics Consortium (IPDGC) has now been in existence for ten years. In an open access article published in the Journal of Parkinson's Disease the consortium reviews the progress made over the past decade in the genomics of Parkinson's disease (PD) and related disorders including Lewy body diseases, progressive supranuclear palsy, and multiple system atrophy and looks ahead at its future direction and research priorities.

Journal of Parkinson’s Disease Welcomes New Co-Editor-in-Chief Bastiaan R. Bloem

January 14, 2020 - Amsterdam, NL – The Journal of Parkinson's Disease (JPD) is pleased to announce the appointment of Prof. Bastiaan (Bas) R. Bloem, MD, PhD, as the journal's new Co-Editor-in-Chief. Bas joins Patrik Brundin, MD, PhD, who along with now Editor Emeritus J. William (Bill) Langston, MD, has led the journal since its inauguration in 2011.

Is There a Link Between Lifetime Lead Exposure and Dementia?

December 23, 2019 - Toronto, ON, Canada – To the medical community’s surprise, several studies from the US, Canada, and Europe suggest a promising downward trend in the incidence and prevalence of dementia. Important risk factors for dementia, such as mid-life obesity and mid-life diabetes, have been increasing rapidly, so the decline in dementia incidence is particularly perplexing.

Experts Review Evidence Yoga is Good for the Brain

December 16, 2019 - Champaign, IL, USA – Scientists have known for decades that aerobic exercise strengthens the brain and contributes to the growth of new neurons, but few studies have examined how yoga affects the brain. A review of the science finds evidence that yoga enhances many of the same brain structures and functions that benefit from aerobic exercise.

The Right Mouse Model Is Crucial for Huntington’s Disease Drug Development

December 11, 2019 - Amsterdam, NL – Huntington's disease (HD) is an incurable and fatal hereditary disease. Developing disease-modifying drugs to treat patients with HD depends on studying them in animal models. Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to their studies. Their findings are published in the Journal of Huntington's Disease.

Huntington’s Disease Patients Need Better Understanding of Risks and Benefits of Clinical Trials

December 10, 2019 - Amsterdam, NL – For patients with Huntington's disease (HD), clinical trials can offer hope when there are no treatments available despite unknowns about whether the therapy will work or is safe. A new study in the Journal of Huntington's Disease found that although the HD community appears highly optimistic about HD research, patients are at risk for therapeutic misconception. In order to allay patients' misgivings, investigators recommend improvements to patient-doctor communication to better convey trial goals, risks and benefits.

New Study Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-Moderate Alzheimer’s Disease

November 27, 2019 - Aberdeen, UK and Singapore, Singapore – In a paper published in today's online issue of the Journal of Alzheimer's Disease, TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the brain in over 1,000 patients with mild-to-moderate Alzheimer's disease. These results showed that, even at the lowest dose of hydromethylthionine previously tested in two Phase 3 global clinical trials (8 mg/day), the drug produced concentration-dependent effects on cognitive decline and brain atrophy.

Psychological Well-Being at 52 Years Could Impact on Cognitive Functioning at 69 Years

November 26, 2019 - Tokyo, Japan – People around the world are living longer, and dementia has consequently become recognized as a public health priority in many countries. The Lancet Commission paper in 2017 collated a large body of medical research evidence that aims to address the dementia epidemic and following challenge for health and social care. It is estimated that as much as 35% of dementia cases could be prevented by targeting nine modifiable risk factors. However, relatively little is known about psychological well-being in this context.

Oligomerix and Feinstein Institutes Publish In Vivo Alzheimer’s Disease Treatment Data

November 20, 2019 - New York, USA – Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease (AD) and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced today the publication of preclinical data demonstrating that an oral small molecule drug inhibits the formation of neurotoxic tau oligomers in an animal model of tau aggregation most relevant to AD. The study showed that the compound blocked tau self-association, which is the earliest step in the toxic tau aggregation cascade, and inhibited the downstream events that lead to tau fibril formation.

Fecal Transplantation to Treat Patients with Parkinson’s Disease: Hope or Hype?

November 15, 2019 - Amsterdam, NL – Constipation is a common complaint in patients with Parkinson's disease. Fecal microbiome transplantation (FMT) and pre- and probiotics are potential options for treating constipation and restoring the microbiome of patients with Parkinson’s disease (PD), but scientists warn that clinical data are scarce, and more research is needed before supporting their use. They present their findings in a review article in the Journal of Parkinson's Disease.

Getting to the “Art” of Dementia: UC Researchers Highlight Benefits of Art Intervention

November 14, 2019 - Canberra, Australia – University of Canberra researchers have shown that art gallery programs can improve the wellbeing of people living with dementia – and they’ve backed it up by testing study participants’ saliva. The study is published in the Journal of Alzheimer's Disease, the UC study monitored new participants of the National Gallery of Australia's (NGA) Art and Dementia program over six weeks. The NGA program has been running for more than 12 years and has demonstrated anecdotal and observational benefits, now backed up by UC research.

Inflammatory Bowel Disease Appears to Impact Risk of Parkinson’s Disease

November 14, 2019 - Amsterdam, NL – Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of Parkinson's Disease, Tomasz Brudek, PhD, evaluates evidence for the association between inflammatory bowel disease (IBD) and PD and proposes directions for future research.

Targeting Alpha-Synuclein in the Gut May Slow Down Parkinson’s Disease

November 13, 2019 - Amsterdam, NL – Aggregates of the protein alpha-synuclein arising in the gut may play a key role in the development of Parkinson's disease (PD). Investigators are testing the hypothesis that by targeting the enteric nervous system with a compound that can inhibit the intracellular aggregation of alpha-synuclein, they can restore enteric functioning in the short term, and possibly slow the progressive deterioration of the central nervous system in the long term. They review results to date in the Journal of Parkinson's Disease.

Researchers Develop a New Home-Based App to Better Monitor Parkinson’s Disease Motor Symptoms

November 12, 2019 - Amsterdam, NL – In order to optimally treat motor symptoms in patients with Parkinson's disease (PD), it is necessary to have a good understanding of their severity and daily fluctuations. A report in the Journal of Parkinson's Disease describes how a new app, SleepFit, could be a useful tool in routine clinical practice to monitor motor symptoms and facilitate specific symptom-oriented follow-up. The researchers also determined that information obtained prospectively in real time from the user-friendly app can differ from data gathered retrospectively from patient interviews.

Nusinersen Improves Motor Function in Adults with Spinal Muscular Atrophy

November 11, 2019 - Amsterdam, NL – A study published in the Journal of Neuromuscular Diseases presents the first evidence of mild improvement or stabilization of motor and respiratory function in adults with spinal muscular atrophy type 3 (SMA3) treated with Nusinersen, which was the case even in patients who have had the disease for 20 years or more. These findings prove the efficacy of Nusinersen beyond types and age groups, paving the way for adult treatment.

What Do We Know About the Gut Microbiota in Parkinson’s Disease?

November 11, 2019 - Amsterdam, NL – Since the discovery that the gut microbiome may play a role in the development of Parkinson's disease (PD), this fresh scientific approach has produced varying results. In this review published in the Journal of Parkinson's Disease scientists compare results of current research and provide recommendations to increase the comparability and utility of these studies with a view towards improving patient outcomes.

Researchers Report New Insights Into Parkinson’s Disease-Related Mortality

November 8, 2019 - Amsterdam, NL – By following a group of newly diagnosed patients with Parkinson's disease (PD) for a decade or more, researchers have been able to identify several factors never before reported that appear to be associated with higher mortality rates in PD patients compared to the general population. As reported in the Journal of Parkinson's Disease, these factors are early onset of PD, early impairment of memory and thinking, and early motor symptoms requiring the start of drug therapy.

Where Does Parkinson’s Disease Start? In the Brain or Gut? Or Both?

November 7, 2019 - Amsterdam, NL – Does Parkinson's disease (PD) start in the brain or the gut? In a new contribution published in the Journal of Parkinson's Disease, scientists hypothesize that PD can be divided into two subtypes: gut-first, originating in the peripheral nervous system (PNS) of the gut and spreading to the brain; and brain-first, originating in the brain, or entering the brain via the olfactory system, and spreading to the brainstem and peripheral nervous system.

In Blacks with Alzheimer’s Gene, Higher Education May Be Protective

October 31, 2019 - New York, NY, USA – Education may erase the risk of cognitive decline associated with the APOE e4 gene – the biggest genetic risk factor for late-onset Alzheimer's disease – in older non-Hispanic black people, according to a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons. The study was published online (pre-press) in the Journal of Alzheimer's Disease.

Looking at the Way We Walk Can Help Predict Cognitive Decline

October 28, 2019 - Amsterdam, NL – The way people walk is an indicator of how much their brains, as well as their bodies, are aging. Scientists reporting in a special supplement to the Journal of Alzheimer's Disease (JAD) say that gait disorders, particularly slowing gait, should be considered a marker of future cognitive decline. They propose testing motor performance as well as cognitive performance in older adults with mild cognitive impairments.

Study Identifies Brain Injury as a Cause of Dementia in Some Older Adults

October 23, 2019 - Los Angeles, CA, USA – A UCLA-led study finds that, with the use of magnetic resonance image (MRI) scans, it is possible to distinguish between memory loss caused by Alzheimer's disease and traumatic brain injury.

Q-Suite Motor Assessment Tool Promising for Evaluating Huntington’s Disease Therapies in Children

October 22, 2019 - Amsterdam, NL – In clinical trials of adults with Huntington's disease (HD) the Q-Suite Motor Assessment Tool (Q-Motor) has proven to be helpful to detect and quantitate subtle motor abnormalities. With the anticipated arrival of preventive gene therapies that will most likely be administered to young children known to be carriers of the HD mutation, it is crucial to have a means to evaluate motor abilities in children that is sensitive to the child's stage of development. Promising results of a feasibility study published in the Journal of Huntington's Disease, indicate that Q-Motor can address this need.

Two of a Kind: Emory Study of Twins Shows What’s Good for the Heart is Good for the Brain

October 21, 2019 - Atlanta, GA, USA – Emory University researchers are giving us double the reasons to pay attention to our cardiovascular health – showing in a recently published study in the Journal of Alzheimer's Disease that good heart health can equal good brain health.

Stem Cell Research Leads to Insights Into How Huntington’s Disease Develops

October 21, 2019 - Amsterdam, NL – Huntington's disease (HD) is a fatal hereditary disease for which there is no cure. A novel study from Cedars-Sinai Medical Center, Los Angeles, USA, using pluripotent stem cells advances understanding of how the disease develops and may help pave the way for identifying pathways for future treatments. Results are published in the Journal of Huntington’s Disease.

How and Why Does Parkinson’s Disease Affect Women and Men Differently?

September 25, 2019 - Amsterdam, NL – There is growing evidence that Parkinson's disease (PD) affects women and men differently. In this insightful review, published in the Journal of Parkinson's Disease, scientists present the most recent knowledge about these sex-related differences and highlight the significance of estrogens, which play an important role in the sex differences in PD.

Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves

September 17, 2019 - Phoenix, AZ, USA – There is finally some encouraging news for the millions of Americans suffering from Alzheimer’s disease. NeuroEM Therapeutics today announced findings from an open label clinical trial showing reversal of cognitive impairment in Alzheimer’s Disease patients after just two months of treatment using the company’s wearable head device for in-home treatment. Results demonstrate that TEMT was safe in all eight participating patients with mild to moderate AD and enhanced cognitive performance in seven of them, as measured by their ADAS-cog score, which is the benchmark for testing AD therapeutics. The open access study is published in the new issue of the Journal of Alzheimer’s Disease.

New Insights: Dementia, Risk, Risk Reduction, and Translation into Practice

September 3, 2019 - Amsterdam, NL – Globally, dementia cases are increasing at a rate of more than 20% a year. Most of these cases are in low- to middle-income countries. In an open access to the Journal of Alzheimer’s Disease, from the International Research Network on Dementia Prevention (IRNDP), an international group of scientists presents new research from around the world examining the potential risk factors for dementia and how to reduce them.

Fatigue in Parkinson’s Disease Is Associated with Lower Diastolic Blood Pressure

August 22, 2019 - Amsterdam, NL – Fatigue is a common debilitating symptom in Parkinson's disease (PD). A novel research study has found that fatigue symptoms in PD are associated with small but persistent reductions in diastolic blood pressure (DBP) throughout the day, report scientists in the Journal of Parkinson's Disease.

Migraine Diagnoses Positively Associated with All-Cause Dementia and Alzheimer’s Disease in Women in the UK

August 14, 2019 - Frankfurt, Germany – Several studies have recently focused on the association between migraine headaches and other headaches and dementia and found a positive migraine-dementia relationship. However, most of these studies have failed to simultaneously adjust for several common comorbidities, thus potentially introducing bias into their findings.

Measuring the Brain’s Amyloid Buildup Less Effective in Identifying Severity, Progression of Alzheimer’s Disease Compared to Other Imaging Methods

August 7, 2019 - Philadelphia, PA, USA – While the presence of beta-amyloid plaques in the brain may be a hallmark of Alzheimer’s disease, giving patients an amyloid PET scan is not an effective method for measuring their cognitive function, according to a new study from researchers in the Perelman School of Medicine at the University of Pennsylvania and Thomas Jefferson University.

Analysis Reveals Economic Cost of Alzheimer’s Disease and Dementia are “Tip of the Iceberg”

July 29, 2019 - Cambridge, UK – A new research review highlighting the hidden costs of dementia suggests that traditional measures only show the "tip of the iceberg" of the cost impact on society. The analysis, from an international team of experts from academia, research institutes, health care organizations, consulting firms and Alzheimer's Research UK, looked at the true cost of Alzheimer's disease and Related Dementias (ADRD). The study found that socioeconomic costs such as the cost of healthcare for care partners/carers, reduced quality of life and "hidden" costs that stack up before diagnosis are overlooked by current estimates of the condition's economic impact. The authors argue that better data on the extent of these costs is vital for informing future dementia policy. The paper is published in the Journal of Alzheimer’s Disease.

New Analysis Shows Drug Slows Down Respiratory Decline in Patients with Duchenne Muscular Dystrophy in Three Clinical Trials

July 9, 2019 - Amsterdam, NL – Duchenne muscular dystrophy occurs in boys and is characterized by progressive muscle degeneration and weakness leading to a decline in respiratory function. Strategies to arrest this severe progressive deterioration are needed to extend lives and improve quality of life. Results of three clinical trials using eteplirsen, an exon-skipping antisense oligonucleotide, show promising results, according to a study published in the Journal of Neuromuscular Diseases.

Yan-Jiang Wang and Xian-Le Bu Receive 2019 Alzheimer Award

July 2, 2019 - Amsterdam, NL – The Journal of Alzheimer's Disease (JAD) is pleased to announce that Yan-Jiang Wang, MD, PhD, and Xian-Le Bu, MD, PhD, both of Daping Hospital, Third Military Medical University, Chongqing, China, are joint recipients of the 2019 Alzheimer Award.

Researchers Identify Potential Modifier Genes in Patients with Charcot-Marie-Tooth Disease

June 18, 2019 - Amsterdam, NL – Charcot-Marie-Tooth (CMT) disease is the most common inherited neurological disorder affecting peripheral motor and/or sensory nerves in humans. Monogenic disorders like CMT1A, CMT’s most prevalent subtype, are caused by a single gene defect. However, its clinical presentation and severity can vary widely, leading doctors to wonder what factors might be responsible for these differences. A study published in the Journal of Neuromuscular Diseases reveals that while all patients with CMT1A share a single gene defect, at least four clinical characteristics were found to be associated with secondary modifying genes.

Moral Emotions, a Diagnostic Tool for Frontotemporal Dementia?

June 14, 2019 - Paris, France – A study conducted by Marc Teichmann and Carole Azuar at the Brain and Spine Institute in Paris, France and at the Pitié-Salpêtrière Hospital shows a particularly marked impairment of moral emotions in patients with frontotemporal dementia (FTD). The results, published in the Journal of Alzheimer's Disease, open a new approach for early, sensitive and specific diagnosis of FTD.

Specific Multinutrient Combination Benefits Patients with Early Stage Alzheimer’s Disease

June 12, 2019 - Amsterdam, NL – A new longitudinal study has shown that a nutritional drink* designated a "food for special medical purposes" containing the multinutrient combination Fortasyn Connect® can benefit patients with the earliest stages of Alzheimer's disease (AD), mild cognitive impairment, who are at risk of progressing to the dementia stage of AD, report scientists in the Journal of Alzheimer's Disease Reports.

Opioid Analgesics Increase the Risk of Pneumonia Among Persons with Alzheimer’s Disease

June 11, 2019 - Kuopio, Finland – Opioid analgesics were associated with a 30% increase in the risk of pneumonia in persons with Alzheimer's disease, a recent study from the University of Eastern Finland shows. The risk was most pronounced in the first two months of use. This is the first study to investigate the association between opioids and pneumonia in this population. The results were published in the Journal of Alzheimer's Disease.

Antihypertensive Drug Use Associated with a Decreased Dementia Risk in Almost 25,000 Elderly Persons Followed in General Practices in Germany

June 3, 2019 - Frankfurt, Germany – Various clinical trials indicate what effects can be expected from standardized intervention programs on the basis of existing evidence. Little is known about the way in which such programs can be implemented in actual care practice. However, it may be possible to use data from clinical practice to estimate the potential of drug prescriptions to delay or reduce the development of dementia.

Hearing Through Your Fingers: Device that Converts Speech to Touch Enables the Hearing-Impaired to Hear Through Their Fingertips

June 3, 2019 - Amsterdam, NL – A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect." The device can provide immediate multisensory enhancement without any training.

When Designing Clinical Trials for Huntington’s Disease, First Ask the Experts: The Patients

April 23, 2019 - Amsterdam, NL – Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments. How best to design clinical trials in which HD patients are willing to participate and comply is a question faced by researchers. For that reason, investigators in the Perelman School of Medicine at the University of Pennsylvania (Penn) surveyed HD patients at different stages of the disease about their attitudes and treatment goals. The results, published in the Journal of Huntington's Disease, should be useful for designing future clinical trials of gene therapies for HD and other genetic disorders.

Abnormalities in a Protein Affecting How Nerve Cells Change Shape May Be Linked to Huntington’s Disease

April 3, 2019 - Amsterdam, NL – Since 1993, when the gene that causes Huntington's disease (HD) was identified, there has been intense focus on understanding how this genetic mutation causes the disease's severe progressive neural deterioration. In a new study published in the Journal of Huntington's Disease, investigators have discovered that the HD mutation may alter the interactions of Huntingtin, the large protein produced by the HD gene, with Rac1, a protein that directs changes in cell shape. In HD, this interaction may result in abnormalities in the pathway controlling neural cell shape and dendritic growth, which can affect how well nerve cells communicate with one another.

Study Published in Journal of Alzheimer’s Disease Finds No Causal Link Between Smoking and Dementia

March 26, 2019 - Lexington, KY, USA – It's an irrefutable fact that smoking is bad for you. Study after study has proven that smoking increases your risk for cancer, heart disease, diabetes – even blindness. But dementia? Not so fast. A recent study published in the Journal of Alzheimer's Disease has demonstrated that smoking is not associated with a higher risk of dementia.

NUS Study: Eating Mushrooms May Reduce the Risk of Cognitive Decline

March 13, 2019 - Singapore, Singapore – A team from the Department of Psychological Medicine and Department of Biochemistry at the Yong Loo Lin School of Medicine at the National University of Singapore (NUS) has found that seniors who consume more than two standard portions of mushrooms weekly may have 50 per cent reduced odds of having mild cognitive impairment (MCI).

Exercise Can Improve Non-Motor Symptoms of Parkinson’s Disease

March 4, 2019 - Amsterdam, NL – Exercise has potential to improve non-motor as well as motor symptoms of Parkinson's disease (PD), including cognitive function, report investigators in a review published in the Journal of Parkinson's Disease.

New Treatment Offers Potentially Promising Results for the Possibility of Slowing, Stopping, or Even Reversing Parkinson’s Disease

February 27, 2019 - Amsterdam, NL – A pioneering clinical trials program that delivered an experimental treatment directly to the brain offers hope that it may be possible to restore the cells damaged in Parkinson's disease. The study investigated whether boosting the levels of a naturally-occurring growth factor, Glial Cell Line Derived Neurotrophic Factor (GDNF), can regenerate dying dopamine brain cells in patients with Parkinson's and reverse their condition, something no existing treatment can do. Potentially promising results of the third arm of the trials, an open access open-label extension study, are reported in the Journal of Parkinson's Disease.

Possible Pathway to New Therapy for Alzheimer’s Disease

February 26, 2019 - Boston, MA, USA – Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease (AD).

New Drug for Duchenne Muscular Dystrophy Clears Phase 1 Clinical Trial Testing in Boys

February 21, 2019 - Amsterdam, NL – Patients with Duchenne muscular dystrophy (DMD) have few treatment options. Medications currently available or in development either target only a subset of DMD patients with a particular genetic mutation or cause significant side effects. The investigational drug edasalonexent, an oral NF-κB inhibitor, has the potential to slow the progression of the disease for all patients with DMD. The results of a Phase I clinical trial published in the Journal of Neuromuscular Diseases indicate that the drug was well tolerated with no safety issues in boys with DMD, paving the way for further clinical testing.

Can We Repair the Brain? The Promise of Stem Cell Technologies for Treating Parkinson’s Disease

February 14, 2019 - Amsterdam, NL – Cell replacement may play an increasing role in alleviating the motor symptoms of Parkinson's disease (PD) in future. Writing in an open access special supplement to the Journal of Parkinson's Disease, experts describe how newly developed stem cell technologies could be used to treat the disease and discuss the great promise, as well as the significant challenges, of stem cell treatment.

No Association Between Antiepileptic Drug Use and Dementia Risk

February 13, 2019 - Frankfurt, Germany – Epilepsy is a common neurological condition with a prevalence of around 2%. Many antiepileptic drugs (AED) are available to prevent epileptic seizures, allowing up to 80 percent of patients to become seizure-free. However, previous research has found a positive association between the use of AEDs and dementia.

The Search for the Holy Grail: Promising Strategies for Slowing, Stopping, or Reversing Parkinson’s Disease

February 12, 2019 - Amsterdam, NL – Understanding of the processes involved in Parkinson's disease (PD) degeneration has vastly improved over the last 20 years. In this insightful review published in an open access special supplement to the Journal of Parkinson's Disease, experts consider which of the existing strategies to slow down or stop the degenerative processes of PD are most likely to be successful over the next 20 years.

The Involvement of the Gut in Parkinson’s Disease: Hype or Hope?

February 7, 2019 - Amsterdam, NL – There is growing evidence that at least in some patients with Parkinson's disease (PD), the disease may begin in the gut. Writing in an open access special supplement to the Journal of Parkinson's Disease, experts explore the last two decades of research about the gut–brain axis in PD and look ahead at the possible development and impact of these research areas in the next two decades.

Expand the Role of Patients, the True Experts, in Neuromuscular Disease Research, Concludes International Workshop

February 6, 2019 - Amsterdam, NL – The old-fashioned paternalistic relationship between doctors and patients has gradually evolved into a more collaborative one in the era of patient-centered medicine. Shared decision-making (SDM), in which doctors and patients jointly decide on treatment or care, has emerged as a gold standard model of healthcare. Yet considerably less attention has been given to obtaining the patient’s perspective on neuromuscular research on such matters as research objectives, study design, or even consent. A position paper in the Journal of Neuromuscular Diseases describes conclusions reached at an international workshop that focused on finding creative solutions to integrate and enhance the patient's point of view in neuromuscular research.

Yoga Regimen Reduces Severity of Rheumatoid Arthritis Symptoms, Alleviates Depression, and Improves Patient Quality of Life

February 5, 2019 - Amsterdam, NL – According a study published in Restorative Neurology and Neuroscience, eight weeks of intensive yoga practice significantly decreases the severity of physical and psychological symptoms in patients with active rheumatoid arthritis (RA), a debilitating chronic auto-immune inflammatory disease. Marked improvements were seen in the levels of certain inflammatory biomarkers and assessments of functional status and disease activity in patients studied, demonstrating yoga’s promotive, preventive, curative, and rehabilitative potential for achieving optimal health.

Experts Propose Revising the Criteria for Diagnosis of Parkinson’s Disease with a View Towards Earlier Treatment and Prevention

February 5, 2019 - Amsterdam, NL – In the past 25 years, it has become clear that some symptoms of Parkinson's disease (PD) occur decades before the development of motor symptoms and clinical diagnosis, and that monitoring these emerging symptoms may provide important insights into the origin and development of the disease. Understanding this "prodromal" phase, along with the development of new treatments, may enable earlier treatment to prevent the disease from developing, according to experts writing in a supplement to the Journal of Parkinson's Disease.

The Search for Environmental Causes of Parkinson’s Disease Moves Forward

January 31, 2019 - Amsterdam, NL – Environmental factors are widely believed to play a key role in the development of Parkinson's disease (PD), but little is known about specific environmental triggers. Writing in a supplement to the Journal of Parkinson's Disease, scientists review novel research hypotheses and approaches that may help better define the role of environment in the development of PD, especially before a diagnosis can be made based on the characteristic motor dysfunction for which PD is known.

Expert-Based Clinical Guidelines Focus on Behavioral Symptoms in Huntington’s Disease

January 30, 2019 - Amsterdam, NL – Although Huntington’s disease (HD) is traditionally thought of as a neurological disorder, behavioral symptoms are a common feature and frequently cause distress and difficulty to patients, family members, and other caregivers. Since an estimated 70% of US patients with HD do not seek specialist care, they are often treated by general practitioners, general neurologists, and psychiatrists, many of whom may not be trained to recognize or treat HD-related behavioral symptoms.

Emerging Evidence of an Impending Parkinson’s Disease Pandemic Identified

January 29, 2019 - Amsterdam, NL – For most of human history Parkinson’s disease (PD) has been a rare disorder. However, demography and the by-products of industrialization are now contributing to an impending Parkinson’s pandemic, according to experts writing in a supplement to the Journal of Parkinson's Disease. They say that this pandemic can be addressed by the Parkinson’s community forming a "PACT" to prevent the disease, advocate for policies and resources aimed at slowing its spread, care for all those affected, and treat with effective and novel therapies.

In Life and Death, Alzheimer’s Disease Looks Different among Hispanic Patients

January 28, 2019 - San Diego, CA, USA – Researchers at Shiley-Marcos Alzheimer’s Disease Research Center (ADRC), part of University of California San Diego School of Medicine, report that autopsies of patients diagnosed with Alzheimer’s disease (AD) when they were alive – and confirmed by autopsy – indicate many cognitive issues symptomatic of the condition are less noticeable in living Hispanic patients.

Psychological Distress is a Risk Factor for Dementia: Results from a Danish Population-Based Study

January 17, 2019 - Copenhagen, Denmark – A new study suggests that vital exhaustion – which can be perceived as an indicator of psychological distress – is a risk factor for future risk of dementia. Researchers from the Department of Public Health, University of Copenhagen have, in collaboration with the National Research Centre for the Working Environment, and the Danish Dementia Research Centre, shown that being distressed in late midlife is associated with a higher risk of dementia in later life.

Air Pollution in Mexico City is Associated with the Development of Alzheimer’s Disease in Children and Young Adults

December 21, 2018 - Missoula, MT, USA – A new study by researchers at the Universities of Montana, Valle de México, Boise State, Universidad Veracruzana, Instituto Nacional de Pediatría and Paul-Flechsig-Institute for Brain Research heightens together with German company Analytik Jena concerns over the evolving and relentless Alzheimer’s pathology observed in young Metropolitan Mexico City (MMC) urbanites. These findings are published in the Journal of Alzheimer’s Disease.

Monitoring Lung Function at Home in Teens with Duchenne Muscular Dystrophy Just Got Easier

December 17, 2018 - Amsterdam, NL – Heart and lung complications are responsible for much of the morbidity and mortality associated with Duchenne muscular dystrophy (DMD). Although regular monitoring of pulmonary function is recommended in order to detect deterioration, compliance with routine testing, such as hospital-based spirometry, is frequently poor. A new study in the Journal of Neuromuscular Diseases describes the at-home use of a child-compatible, hand-held device that makes monitoring pulmonary function in teens more convenient and provides the data needed for better disease management.

Addressing Sleep Disorders After Traumatic Brain Injury Should Be a Cornerstone of Treatment, Say Researchers

December 10, 2018 - Amsterdam NL – Disorders of sleep are some of the most common problems experienced by patients after traumatic brain injury (TBI). It is important to recognize and treat these problems early to allow for optimal cognitive recovery, but because they are so common, the importance of treating them is often underestimated. In this special issue of NeuroRehabilitation, scientists address the interplay of sleep and TBI with the aim of improving both diagnosis and treatment of these problems.

Experts Explore the Role of Neurogenesis in Brain Disorders

November 28, 2018 - Amsterdam, NL – Mutations in genes or environmental insults that alter neurogenesis, the growth and development of neurons, are the cause of many neurological and psychiatric disorders. This special issue of Brain Plasticity focuses on the role of neurogenesis in brain disorders.

Meditation and Music May Alter Blood Markers of Cellular Aging and Alzheimer’s Disease in Adults with Early Memory Loss

November 12, 2018 - Morgantown, WV, USA – A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer’s Disease in older adults who are experiencing memory loss.

U.S. Businessman Issues Global, Multimillion Dollar (USD) Challenge for Innovative Alzheimer’s Solutions

November 5, 2018 - San Antonio, TX, USA – To expand the understanding and explanation of Alzheimer’s disease, United States businessman James Truchard has given a $5 million USD gift to The University of Texas at San Antonio (UTSA) College of Sciences to establish the Oskar Fischer Project.

Early Alzheimer’s Brain Pathology Linked to Psychiatric Symptoms

October 25, 2018 - San Francisco, CA, USA – UC San Francisco researchers, in collaboration with the unique Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, have shown that the earliest stages of the brain degeneration associated with Alzheimer’s disease (AD) are linked to neuropsychiatric symptoms including anxiety, depression, loss of appetite, and sleep disturbances.

Long-Running Study Identifies Modifiable Dementia Risk Factor in Older Adults

October 22, 2018 - Pittsburgh, PA, USA – For older adults, it may seem as though the die is already cast regarding their odds of developing dementia, but new research from the University of Pittsburgh has identified a dementia risk factor among older adults that should be modifiable even well into old age.

Hypothesis Underpinning Dementia Research ‘Flawed’

October 19, 2018 - Manchester, UK – A hypothesis which has been the standard way of explaining how the body develops Alzheimer’s disease for almost 30 years is flawed, according to a University of Manchester biologist.

A New Study Indicates Measuring the Progression of Alzheimer’s Disease by Monitoring Major Brain Antioxidant Levels Using Non-Invasive Techniques

October 12, 2018 - Gurgaon, India – In a breakthrough human study published in the Journal of Alzheimer's Disease, anti-oxidant, glutathione (GSH), which protects the brain from stress, has been found to be significantly depleted in Alzheimer's patients compared to normal subjects.

NeuroRehabilitation Begins Publication of Evidence-Based Cochrane Systematic Reviews Summaries

September 24, 2018 - Amsterdam, NL – IOS Press is pleased to announce a new affiliation between NeuroRehabilitation (NRE) and Cochrane Rehabilitation with the aim of improving evidence-based neurorehabilitation practice. Abstracts from specially selected Cochrane Systematic Reviews relevant to neurorehabilitation will be published in NRE in a new section called Cochrane Corners.

Optimizing Dopaminergic Treatment Improves Non-Motor Symptoms in Severe Parkinson’s Disease

September 24, 2018 - Amsterdam, NL – Non-motor symptoms are common in late stage Parkinson’s disease (PD) as the frequency and severity of most of these symptoms increase with advancing disease. Optimizing dopaminergic treatment in the most severe stages can affect non-motor symptoms and improve quality of life, report scientists in the Journal of Parkinson’s Disease.

Eradicating Helicobacter pylori Infections May Be a Key Treatment for Parkinson’s Disease

September 24, 2018 - Amsterdam, NL – While human genetic mutations are involved in a small number of Parkinson’s disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.

Can a Novel High-Density EEG Approach Disentangle the Differences of Visual Event Related Potential (N170), Elicited by Negative Facial Stimuli, in People with Subjective Cognitive Impairment?

September 14, 2018 - Thessaloniki-Macedonia, Greece – Greek researchers investigated whether specific brain regions, which have been found to be highly activated after negative facial stimulus, are also activated in different groups of people with subjective cognitive impairment (SCI), mild cognitive impairment (MCI) and Alzheimer’s disease (AD) compared to healthy controls (HC).

Parkinson Matters: A Call to Action to Improve Patient Care

September 10, 2018 - Amsterdam, NL – Deaths associated with Parkinson’s disease and related disorders increased substantially between 2001 and 2014. Parkinson’s disease was in fact the most common cause of death associated with a neurological condition, according to a report by Public Health England. International experts reporting in the Journal of Parkinson’s Disease evaluate these findings and address important implications for future healthcare needs.

World Alzheimer’s Month – Increasing Awareness: Share & Win!

September 3, 2018 - Amsterdam, NL – Every year in September across the globe, efforts are made to increase awareness of AD and dementia – and the ongoing research into the disease – during World Alzheimer's Month (WAM). Join with the Journal of Alzheimer's Disease in supporting WAM this year, by spreading awareness of the impact JAD has and what our journal achieves in terms of advancing knowledge in the field, and you could be enter a draw to win a copy of our latest book!

Largest Brain Study of 62,454 Scans Identifies Drivers of Brain Aging

August 21, 2018 - Costa Mesa, CA, USA – In the largest known brain imaging study, scientists from Amen Clinics (Costa Mesa, CA), Google, John’s Hopkins University, University of California, Los Angeles and the University of California, San Francisco evaluated 62,454 brain SPECT (single photon emission computed tomography) scans of more than 30,000 individuals from 9 months old to 105 years of age to investigate factors that accelerate brain aging. SPECT tomography) evaluates regional cerebral blood flow in the brain that is reduced in various disorders.

Impact of Osteoporosis on the Risk of Dementia in Almost 60,000 Patients Followed in General Practices in Germany

August 20, 2018 - Frankfurt, Germany – Osteoporosis is estimated to affect 200 million women across the world. In Germany, the prevalence of this chronic disease among people aged 50 years and older is around 15%. In recent decades, several authors have analyzed the impact of osteoporosis on the risk of cognitive decline, but most of these studies have been conducted outside Europe.

Experts Highlight New Concepts and Approaches to the Rehabilitation of Stroke

August 13, 2018 - Amsterdam, NL – Stroke remains a leading cause of adult disability, and the global burden of stroke continues to grow with devastating consequences for patients, families, and caregivers. In this special issue of NeuroRehabilitation leading international experts on stroke rehabilitation provide theoretical and practical insights into the steps necessary to push beyond merely compensatory training and onto a level of recovery that is satisfactory for patients.

Insulin Resistance Under-Diagnosed in Non-Diabetics with Parkinson’s Disease

August 3, 2018 - Amsterdam, NL – Almost two-thirds of non-diabetic patients with Parkinson’s disease (PD) may be insulin resistant, despite having normal blood sugar, report scientists in the Journal of Parkinson’s Disease. Their findings suggest that insulin resistance in PD is a common and largely undetected problem, especially in patients who are overweight.

Exenatide Treatment Alleviated Symptoms of Depression in Patients with Moderate Parkinson’s Disease

August 1, 2018 - Amsterdam, NL – Non-motor symptoms of Parkinson’s disease (PD), such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on health-related quality of life than motor deficits. In a post hoc analysis of the exenatide-PD trial results, investigators found that patients on exenatide treatment experienced improvements in severity of depression, independent of whether their motor function improved.

Naturalistic Driving Study Investigates Self-Regulation Behavior in Early Alzheimer’s Disease

July 27, 2018 - Lyon, FR – Driving is a complex task that involves perceptual, motor and cognitive abilities. These abilities may be affected in early Alzheimer's disease (AD) patients. Nevertheless, they continue to drive for more years than people with other dementia syndromes perhaps because of a deficit in self-awareness that prevents them from perceiving their driving difficulties and adapting accordingly. The purpose of the present pilot study was to closely examine the self-regulation behavior of older individuals with AD using a naturalistic driving approach.

Early Treatment with Nusinersen Can Mean Better Outcomes for Babies with Spinal Muscular Atrophy

July 16, 2018 - New findings suggest SMA should be routinely included in newborn screening for early diagnosis, according to research published in the Journal of Neuromuscular Diseases

Greg Kennedy Honored with 2018 Alzheimer Award

July 16, 2018 - Amsterdam, NL – The Journal of Alzheimer’s Disease (JAD) is pleased to announce that Greg Kennedy, a PhD candidate at the Centre for Human Psychopharmacology, Swinburne University of Technology, Hawthorn, Australia, has been chosen as the recipient of the 2018 Alzheimer Award.

Could This Be The Solution For Alzheimer’s Disease? =[L+MZ+Z+DHA+EPA]

June 20, 2018 - Waterford, Ireland – Ground-breaking new research has identified a unique combination of nutrients to slow the progression of Alzheimer’s disease (AD), which affects over 520,000 people in the UK and represents a burden on the struggling NHS of over £26 billion per year.

Parkinson’s Movement – An Initiative of the CPT in association with JPD – Announces the Quarterly Parkinson’s Webinar Series

June 12, 2018 - Amsterdam, NL – IOS Press is pleased to announce that JPD is working in partnership with The Cure Parkinson’s Trust (CPT) to provide information about breaking research news to be featured on the new web portal for people with Parkinson’s (PwPs) called Parkinson’s Movement. Linked to this initiative is the launch of a new series of Quarterly Parkinson's Webinars.

Better Physical Fitness and Lower Aortic Stiffness Key to Slower Brain Ageing

June 12, 2018 - Melbourne, Australia – The rate of decline in certain aspects of memory may be explained by a combination of overall physical fitness and the stiffness of the central arteries, researchers from Swinburne’s Centre for Human Psychopharmacology have found.

How Can We Help Children With Brain Injuries Transition Back to School?

May 15, 2018 - Global experts on pediatric brain injury report on the significant challenges, key issues, and proposed solutions to support children and youth when they transition to school in this special issue of NeuroRehabilitation

Gait Assessed with Body-Worn Sensors May Help Detect Onset of Alzheimer’s Disease

May 8, 2018 - Newcastle, UK – Body-worn sensors used at home and in clinic by people with mild Alzheimer’s to assess walking could offer a cost-effective way to detect early disease and monitor progression of the illness. A pilot study involving Newcastle University has revealed low-cost wearable devices could improve clinical trial efficiency and encourage research investment.

Journal of Alzheimer’s Disease Marks its 20th Anniversary with a Milestone Issue Covering 20 years of Alzheimer’s Research

May 1, 2018 - Amsterdam, NL – IOS Press is pleased to announce that 2018 marks the 20th anniversary of the Journal of Alzheimer’s Disease (JAD). One of the many events celebrating this milestone is the publication of an open access issue (JAD 62:3) looking back at 20 years of Alzheimer’s disease (AD) research, which is now available online.

What if You Could Know That Your Mild Cognitive Impairment Wouldn’t Progress in the Next Decade Through the Result of Two Simple Neuropsychological Tests?

April 24, 2018 - Lisbon, Portugal – Researchers from the Lisbon School of Medicine, University of Lisbon found that, in some mild cognitive impairment patients, real neuropsychological stability over a decade is possible and that long-term stability could be predicted based on neuropsychological tests measuring memory and non-verbal abstract reasoning, according to a study published in the Journal of Alzheimer’s Disease.

Late, but Not too Late – Screening for Olfactory Dysfunction as a Marker for Cognitive Impairment in Middle-Aged

April 23, 2018 - Essen, Germany – In a large population-based study of randomly selected participants in Germany, researchers found that participants aged 65–74 years with olfactory dysfunction showed impaired cognitive performance. Interestingly, this strong association was not present in younger (55–64 years) or older (75–86 years) participants. Additionally, the effect was more present in women than men. The study was led by Sarah Tebruegge and is published in the Journal of Alzheimer’s Disease.

Can a Smell Test Sniff Out Alzheimer’s Disease?

March 28, 2018 - Columbia, US – The sense of smell is one of the first things to change as Alzheimer’s disease takes root, even before other symptoms appear. That’s raised the idea that a scratch-and-sniff test that rates an individual’s ability to identify odors could potentially detect the disease early – allowing patients to begin treatment before symptoms become harder to treat. Columbia neurologist William Kreisl, MD, has been studying a smell identification test and explains what it can – and can’t – say about Alzheimer's.

Detecting Diminished Dopamine-Firing Cells Inside the Brain Could Reveal Earliest Signs of Alzheimer’s Disease

March 27, 2018 - Sheffield, UK – A new link between diminished input from dopamine-firing cells deep inside the brain and the ability to form new memories could be crucial in detecting the earliest signs of Alzheimer's disease.

Brain SPECT Imaging Predicts Outcomes in Depressed Patients

March 20, 2018 - Costa Mesa, US – New research from the Amen Clinics shows that brain SPECT (single photon emission computed tomography) imaging, a study that measures blood flow and activity patterns, identifies who is likely to get better from depression and who is not. The study is published in the Journal of Alzheimer's Disease, because depression is a highly treatable risk for cognitive decline and Alzheimer's disease.

Exploring the Role of Cognitive Factors in a New Instrument for Elders’ Financial Capacity Assessment

March 13, 2018 - Thessaloniki, Greece – Although the general public and mental health professionals seem to disregard incapacity regarding financial issues and relevant decision making in mild cognitive impairment (MCI), and focus only on severe dementia cases, a PhD study in Greece reveals that noticeable deficits do exist in the handling of financial issues in elders suffering from MCI. The results are published in the Journal of Alzheimer’s Disease.

The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer’s Disease

March 12, 2018 - Barcelona, Spain – The ability to generate spoken verbs in infinitive in a given time begins to worsen in the early stages of Alzheimer's disease (AD). Thus, the verb fluency test has been found to be a suitable neuropsychological tool for the detection of healthy aging people at risk of developing cognitive impairment, according to a recent research of the Research Center and Memory Clinic, Fundació ACE, Institut Català de Neurociències Aplicades, UIC-Barcelona, Spain (

Fipronil and Other Pyrazole Insecticides Induce Amyloid-β42 Production

March 7, 2018 - Roscoff, France – A new study led by Laurent Meijer of ManRos Therapeutics shows that some pyrazole insecticides, of which fipronil is an archetype, trigger enhanced in vitro production of Aβ42/Aβ43 over Aβ40 amyloid peptides in a cell-free, highly purified preparation of γ-secretase, in various cell lines and in neurons differentiated from human-induced pluripotent stem cells (iPSCs) from a healthy or a familial Alzheimer’s disease (AD) patient with the APP K724N mutation. Findings are published in the Journal of Alzheimer’s Disease.

Data Detectives Shift Suspicions in Alzheimer’s from Usual Suspect to Inside Villain

February 21, 2018 - Atlanta, US – The mass pursuit of a conspicuous suspect in Alzheimer’s disease may have encumbered research success for decades. Now, a new data analysis that has untangled evidence amassed in years of Alzheimer’s studies encourages researchers to refocus their investigations.

e-Health Can Support Healthy Ageing and Help Preventing Cardiovascular Disease and Dementia in Elderly People

February 20, 2018 - Kuopio, Finland – An innovative e-health solution, based on an interactive internet platform, has been developed to support senior citizens in improving their lifestyle to prevent cardiovascular disease, cognitive decline and dementia.

Poor Fitness Linked to Weaker Brain Fiber, Higher Dementia Risk

February 15, 2018 - Dallas, US – Scientists have more evidence that exercise improves brain health and could be a lifesaving ingredient that prevents Alzheimer’s disease.

Alzheimer’s Disease: Dual Mechanism of Actions of Overactive and Cytosolic BRCA1 in Neuronal Death

February 8, 2018 - Warsaw, Poland – A new study suggests an association between overactive and cytosolic BRCA1, the major guardian of genomic stability, and neuron death in Alzheimer’s disease (AD).

One in Five Older Adults Experience Brain Network Weakening Following Knee Replacement Surgery

February 6, 2018 - Gainesville, US – A new University of Florida (UF) study finds that 23 percent of adults age 60 and older who underwent a total knee replacement experienced a decline in activity in at least one region of the brain responsible for specific cognitive functions. Fifteen percent of patients declined across all brain networks the team evaluated.

People with Down Syndrome Develop Symptoms of Alzheimer’s Disease 20–30 Years Before Others

January 15, 2018 - London, UK – A new multi-centre study published in the Journal of Alzheimer's Disease, led by researchers from King’s College London (KCL) and UCL, has found that people with Down syndrome (DS) develop earlier onset of Alzheimer’s disease (AD), with an average age of diagnosis between 55 and 56.

Neurosexuality Needs to Be Better Addressed in Patients with Neurodisabilities

December 21, 2017 - Experts reporting in NeuroRehabilitation raise awareness of neurosexuality challenges faced by patients with neurodisabilities, including members of the LGBTQIA+ community, and provide guidance for healthcare providers and caregivers to help improve quality of life

Lithium in Water Associated with Slower Rate of Alzheimer’s Disease Deaths

December 5, 2017 - St Catharines, Canada – Trace elements of lithium in drinking water can slow death rates from Alzheimer’s disease, researchers at the Brock University, Canada have found.

Second Phase 3 Study Supports Hypothesis for LMTM as Monotherapy for Alzheimer’s Disease

November 28, 2017 - Aberdeen, UK – TauRx Therapeutics Ltd reported the full results from its second Phase 3 clinical study of LMTM (registered name: LMTX), the first tau aggregation inhibitor in Alzheimer’s disease, which has been published online in the Journal of Alzheimer’s Disease.

Severity of Post-Operative Delirium Relates to Severity of Cognitive Decline

November 28, 2017 - Boston, USA – Researchers from the Harvard affiliated Hebrew SeniorLife Institute for Aging Research (IFAR), in collaboration with scientists from Beth Israel Deaconess Medical Center (BIDMC), Harvard Medical School (HMS), and Brown University, have found increasing evidence that the level of delirium in post-surgical patients is associated with the level of later cognitive decline in those same patients. Findings from this study were published today in the Journal of Alzheimer’s Disease.

Memory Complaints and Cognitive Decline: Data from the GuidAge Study

November 13, 2017 - Toulouse, France – A new study in the Journal of Alzheimer's Disease by researchers at the Paul Sabatier University in Toulouse identifies a 5-item version of the McNair and Kahn Scale for predicting cognitive decline.

Genre May Impact Cognitive Training Using Video Games

October 2, 2017 - Amsterdam, NL – Video games are quickly becoming a hot topic in cognitive training. Many see them as a potential tool to help patients improve their performance and memory, yet little is known about how different types of video games may affect white matter in the brain and cognition.

Novel Genetic Mutation Discovered in Parkinson’s Disease Patient

September 13, 2017 - Amsterdam, NL – Mutations in the human genome may be responsible for many diseases. In the case of Parkinson’s disease (PD), five locations have been the subject of recent attention. Variants of one of these locations, ACMSD (aminocarboxymuconate semialdehyde decarboxylase), may be implicated in PD, but until now, no mutations in ACMSD have been found in any PD patients.

Overcoming Barriers to Recruiting Blacks/African-Americans for Dementia Research

September 6, 2017 - Lexington, USA – In a paper published in the Journal of Alzheimer's Disease, lead author Eseosa Ighodaro, PhD, encouraged fellow researchers to address the challenges associated with studying dementia in Blacks/African-Americans.

Is Telomere Length Associated with the Cognitive Response to a Lifestyle Intervention?

August 28, 2017 - Stockholm, Sweden – A new study from the FINGER trial team shows that participants with shorter leukocyte telomere length (LTL) had more pronounced benefits on cognition following the multidomain lifestyle intervention.

Women Have More Active Brains Than Men

August 7, 2017 - Amsterdam, NL – In the largest functional brain imaging study to date, the Amen Clinics (Newport Beach, CA) compared 46,034 brain SPECT (single photon emission computed tomography) imaging studies provided by nine clinics, quantifying differences between the brains of men and women. The study is published in the Journal of Alzheimer’s Disease.

For White Middle Class, Moderate Drinking Is Linked to Cognitive Health in Old Age

August 2, 2017 - San Diego, US – Older adults who consume alcohol moderately on a regular basis are more likely to live to the age of 85 without dementia or other cognitive impairments than non-drinkers, according to a University of California San Diego School of Medicine-led study.

A Protein Involved in Alzheimer’s Disease May Also be Implicated in Cognitive Abilities in Children

August 1, 2017 - Bergen, Norway – Rare mutations in the amyloid precursor protein (APP) have previously been shown to be strongly associated with Alzheimer’s disease (AD). Common genetic variants in this protein may also be linked to intelligence (IQ) in children, according to recent research performed at the University of Bergen, Norway.

Vascular Risk Factors and Alzheimer’s Disease: A New Therapeutic Opportunity?

August 1, 2017 - Ancona, Italy – Currently, no possibility exists to reliably quantify the risk of Alzheimer’s disease (AD) onset in the general population and in subjects with mild cognitive impairment. Metabolic and genetic factors involved in increasing the probability of developing dementia have already been identified. Some vascular risk factors, as hypertension, dyslipidaemia, diabetes or smoking can cause a derangement in extra or intracranial vessels architecture, which can be responsible for an early aging of the brain. However, reliable tools for early identification of subjects at greater risk of evolution from mild cognitive impairment to AD are not available.

Extended Use of MAO-B Inhibitors Slows Decline in Parkinson’s Disease Patients

March 7, 2017 - According to a new report published in the Journal of Parkinson’s Disease

Altmetric Data Analysis Reveals How Parkinson’s Disease Research Affects the World

February 13, 2017 - London, UK and Boston, USA – ÜberResearch and Altmetric, leading data and analytics companies serving scientific funders and research organizations, have published an analysis of Parkinson’s disease research papers with the highest Altmetric Attention Scores in the Journal of Parkinson’s Disease.

Deep Brain Stimulation Studies in Alzheimer’s Disease Pose Ethical Challenges

January 30, 2017 - Philadelphia, USA – Promising, early studies of deep brain stimulation (DBS) for the treatment of Alzheimer’s disease have paved a path for future clinical trials, but there are unique ethical challenges with this vulnerable population regarding decision making and post-study treatment access that need to be addressed as they ramp up, Penn Medicine researchers argue in a new review in the Journal of Alzheimer’s Disease.

What Matters Most to Huntington’s Disease Patients? New Survey

January 23, 2017 - New York, USA – Huntington’s disease (HD) has no cure and no therapies to slow the course of this fatal disease. HD patients can experience a wide range of cognitive, physical, and psychiatric symptoms. In an effort to gather the perspectives of both HD and Juvenile Huntington’s disease (JHD) patients and their caregivers, the Huntington’s Disease Society of America (HDSA), in conjunction with the U.S. Food and Drug Administration (FDA), conducted two surveys. The first assessed symptoms and their impact on daily life and the second gathered opinions about current approaches to treating HD. Insights gained as the result of these surveys are published in the current issue of the Journal of Huntington’s Disease.

Meditation and music may help reverse early memory loss in adults at risk for Alzheimer’s Disease

January 23, 2017 - Morgantown, USA – In a recent study of adults with early memory loss, a West Virginia University research team lead by Dr. Kim Innes found that practice of a simple meditation or music listening program may have multiple benefits for older adults with preclinical memory loss.

Not All Europeans Receive the Same Care for Duchenne Muscular Dystrophy

January 3, 2017 - Duchenne muscular dystrophy (DMD), a progressive muscle disease affecting one in 3800-6300 live male births and leads to ambulatory loss, respiratory problems, cardiomyopathy, and early death of patients in their 20s or 30s. While incurable, multidisciplinary treatment can raise life expectancy into the fourth decade. However, in a survey across seven European countries, researchers found striking differences in access to appropriate care. There were significant inequities between different countries and different age groups, which would likely lead to different health outcomes.

Promising discovery for a non-invasive early detection of Alzheimer’s disease

December 23, 2016 - A discovery of high relevance in medical research will be published in Volume 55, number 4 of December 2016 of the prestigious “Journal of Alzheimer’s disease (JAD)”, entitled “Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer’s Disease”. This paper has been highlighted as one of the most important contribution to this field. The paper stems from a fruitful collaboration between the neuroscience laboratory from the International Center for Biomedicine (ICC) under the leadership of Dr. Ricardo Maccioni and the research teams of Drs. Andrea Slachevsky, Faculty of Medicine, University of Chile, together with Drs. Oscar Lopez and James Becker from University of Pittsburgh, School of Medicine, USA.

Occupational therapy may have the potential to slow down functional decline and reduce behavioral troubles in dementia patients

December 23, 2016 - Bordeaux, France – A French observational study in real life showed that dementia patients benefiting from occupational therapy sessions report relevant clinical benefits over the intervention period, according to a research study published in the Journal of Alzheimer’s Disease this month. The research suggested the influence of occupational therapy on reducing behavioral troubles, caregivers’ burden and amount of informal care over the intervention period and a stabilization over the 3-months period thereafter.

Penn Study Confirms That “Sniff Test” May Be Useful in Diagnosing Early Alzheimer’s Disease

December 22, 2016 - Tests that measure the sense of smell may soon become common in neurologists’ offices. Scientists have been finding increasing evidence that the sense of smell declines sharply in the early stages of Alzheimer’s, and now a new study from the Perelman School of Medicine at the University of Pennsylvania published in the Journal of Alzheimer’s Disease confirms that administering a simple “sniff test” can enhance the accuracy of diagnosing this dreaded disease.

New biomarker predicts Alzheimer’s disease and link to diabetes

December 22, 2016 - An enzyme found in the fluid around the brain and spine is giving researchers a snapshot of what happens inside the minds of Alzheimer’s patients and how that relates to cognitive decline.

Antipsychotic drug use increases risk of mortality among persons with Alzheimer’s disease

December 20, 2016 - Antipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer's disease, shows a recent study from the University of Eastern Finland. The risk was highest at the beginning of drug use and remained increased in long-term use. Use of two or more antipsychotic drugs concomitantly was associated with almost two times higher risk of mortality than monotherapy. The results were published in the Journal of Alzheimer’s Disease.

JAD’s Alzheimer Funding Analyzer Now Includes Alzheimer’s Association Grants

December 19, 2016 - The Journal of Alzheimer’s Disease (JAD) is pleased to announce that its Alzheimer’s Funding Analyzer (AFA) now includes all Alzheimer’s Association (AA) grants in addition to grants from other funding bodies. AFA is a free service that is part of a suite of online features integrated into the JAD site to meet the needs of the Alzheimer disease (AD) research community.

Higher BMI in Adolescence May Affect Cognitive Function in Midlife

December 12, 2016 - Overweight and obesity in adolescents have increased substantially in recent decades, and today affect a third of the adolescent population in some developed countries. While the dangers posed by high adult BMI on cognitive function in later life have been documented, the association of adolescent BMI with cognitive function in midlife has not yet been reported. (BMI, or Body Mass Index, is a calculation of a person’s weight in kilograms divided by the square of their height in meters.)

New tool to help predict dementia risk in older people

December 12, 2016 - A machine learning method analyzing large amounts of health information has potential in assessing the risk of cognitively healthy older people for later dementia, according to research published in the Journal of Alzheimer’s Disease. The new risk assessment tool also presents the individual risk profile in a quickly interpretable visual form.

Aurin Biotech’s Simple Saliva Test Predicts Future Onset Of Alzheimer’s Disease

November 28, 2016 - Aurin Biotech (, announced that it has developed a simple saliva test that can diagnose Alzheimer’s disease, as well as predict its future onset, allowing individuals to take preventive measures before the disease takes hold.

New Study Shows Marijuana Users have Low Blood Flow to the Brain

November 28, 2016 - As the U.S. races to legalize marijuana for medicinal and recreational use, a new, large scale brain imaging study gives reason for caution. Published in the Journal of Alzheimer’s Disease, researchers using single photon emission computed tomography (SPECT), a sophisticated imaging study that evaluates blood flow and activity patterns, demonstrated abnormally low blood flow in virtually every area of the brain studies in nearly 1,000 marijuana compared to healthy controls, including areas known to be affected by Alzheimer’s pathology such as the hippocampus.

UTMB study offers new insight into how Alzheimer’s disease begins

November 24, 2016 - A new study from The University of Texas Medical Branch at Galveston offers important insight into how Alzheimer’s disease begins within the brain. The researchers found a relationship between inflammation, a toxic protein and the onset of the disease. The study also identified a way that doctors can detect early signs of Alzheimer’s by looking at the back of patients’ eyes.

Hospital Admissions Rising for Elderly Patients with Parkinson’s Disease

November 15, 2016 - Although treatment for Parkinson’s disease (PD) is significantly extending the lives of patients, these patients are now being admitted to hospitals at increasing rates. In a study reported in the Journal of Parkinson’s Disease, researchers in Ireland have found that the top five reasons for hospital admission of PD patients are urinary tract infections, pneumonia, lower respiratory tract infections, aspiration pneumonia and femur fracture. More troubling is the stark increase in PD patients requiring long-term nursing home care on discharge, with 27% of the over 65 group discharged to a nursing home compared to 12% admitted from a nursing home.

Parkinson’s Disease Patients Benefit from Physical Activity

November 15, 2016 - A comprehensive review published in the Journal of Parkinson’s Disease confirms that people living with Parkinson’s disease (PD) can benefit from being physically active, especially when it comes to improving gait and balance, and reducing risks of falls. It concludes that health professionals should be confident about prescribing physical activity to improve the health and quality of life of PD patients.

A Novel and Intelligent Home Monitoring System for Care Support of Elders with Cognitive Impairment

October 31, 2016 - Greek researchers demonstrated the potential use of assistive technologies for people with dementia, to fulfill an important need: the improvement of clinical diagnosis and decision making meeting individual needs.

Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer’s Biomarkers

October 12, 2016 - A peer reviewed study led by Proteome Sciences plc (“Proteome Sciences”), in conjunction with a group of highly respected universities and hospitals, demonstrates the ability of an innovative mass spectrometry (MS) workflow to dramatically improve the ability to detect tau-derived peptides that are directly related to human Alzheimer’s pathology as early stage biomarkers of the disease.

Online advice for preventing Alzheimer’s disease often problematic: UBC research

October 11, 2016 - New UBC research finds that many online resources for preventing Alzheimer’s disease are problematic and could be steering people in the wrong direction.

Specific Triazine Herbicides Induce Amyloid-β42 Production

September 15, 2016 - A new study led by Laurent Meijer, at ManRos Therapeutics, and collaborators shows that some herbicides (triazines) trigger enhanced in vitro production of the Aβ42 over Aβ40 amyloid peptides in various cell lines. This suggests that some products from the ‘human chemical exposome’ (HCE) (estimated to be over 85,000 products) may contribute to the increased production of Aβ42 over Aβ40 characteristic of Alzheimer’s disease (AD). In addition, some of these products might be turned into pharmacological tools to develop a chemically-induced animal model of AD (in contrast with the currently used genetic, recombinant mice models). Publication of these findings is scheduled in the Journal of Alzheimer's Disease, vol. 54(4) issue. This work is now continuing with special focus on (1) Persistent Organic Pollutants (POPs) and (2) defining conditions under which such products could trigger in vivo Aβ42 production in mice.

Markers associated with Alzheimer’s and Parkinson’s diseases are present in Mexico City children chronically exposed to concentrations of fine particulate matter PM2.5 above the current EPA USA standards

September 12, 2016 - A new study by researchers at the Universities of Montana, Valle de México, Boise State, Veracruz University, Médica Sur, Centro de Ciencias de la Atmósfera, UNAM, Hospital Regional de Alta Especialidad, Ciudad Victoria, Hospital de Especialidades #14, IMSS, Centre Hospitalier Universitaire, Hôpital de Hautepierre and AJ Roboscreen GmbH heightens concerns over the detrimental impact of fine particulate matter PM2.5 on CSF markers associated with Alzheimer and Parkinson’s diseases in children ages 11.9±4.8 years. These findings are published in the Journal of Alzheimer’s Disease.

Efficacy and Safety of Crocus Sativus L in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial

September 12, 2016 - Greek researchers and clinicians demonstrated the potential of Crocus Sativus L. (saffron) as a therapeutic pharmaceutical natural compound for older adults with amnestic Mild Cognitive Impairment (aMCI). MCI is a condition that often predates Alzheimer’s disease (AD) and is characterized by memory loss and inability to execute complex Activities of Daily Living. While there is no treatment for MCI and symptomatic only treatment for AD, the global effort against cognitive disorders is focused on early detection and management of AD at the stage of MCI.

Midlife physical activity is associated with better cognition in old age

September 12, 2016 - A long-term follow-up study of 3050 twins from the Finnish Twin Cohort has shown that midlife, moderately vigorous physical activity is associated with better cognition at old age. The association was statistically independent of midlife hypertension, smoking, education level, sex, obesity and binge drinking. This suggests that the beneficial influence of physical activity on the brain and cognition is not solely based on decreasing vascular risk factors.

Subjective Cognitive Decline and risk of future AD dementia – results from a German multi-center study highlights the importance of temporal consistency

September 7, 2016 - A new study, based on longitudinal data from the German Study on Aging, Cognition and Dementia in Primary Care Patients (AgeCoDe), suggests that temporal stability versus instability of an individual’s report of subjective worsening of cognition over time plays an important role with regard to whether such experiences are associated with future dementia risk. These findings, which will be published in the Journal of Alzheimer's Disease 54(3), add to a constantly growing strand of research on the phenomenon of “Subjective Cognitive Decline” (SCD) in Alzheimer’s Disease (AD).

Patients with Moderate to Severe Traumatic Brain Injury Twice as Likely to Die from an Unintentional Injury

August 29, 2016 - Research examining adults with moderate to severe traumatic brain injury (TBI) who participated in rehabilitation showed that they were twice as likely to die from an unintentional injury that occurred following their TBI. This was in comparison to individuals in rehabilitation of similar age, sex, and race but without TBI. People who have had a moderate to severe TBI may experience changes in cognition and balance, which may put them at greater risk of subsequent unintentional injuries. In the current issue of NeuroRehabilitation, experts focus on the issues and risks associated with unintentional injuries following TBI and strategies to mitigate these risks.

BU Study Reveals Association between Physical Function and Neurological Disease

August 25, 2016 - A new study, based on data from the Framingham Heart Study (FHS) suggests a simple test of physical functioning may be able to help physicians identify individuals who are at a higher risk for developing Alzheimer’s disease and stroke.

Inosine Treatment Helps Recovery of Motor Functions after Brain Injury

August 3, 2016 - Brain tissue can die as the result of stroke, traumatic brain injury, or neurodegenerative disease. When the affected area includes the motor cortex, impairment of the fine motor control of the hand can result. In a new study published in Restorative Neurology and Neuroscience, researchers found that inosine, a naturally occurring purine nucleoside that is released by cells in response to metabolic stress, can help to restore motor control after brain injury.

Current Screening Methods Miss Worrisome Number of Persons with Mild Cognitive Impairment

August 2, 2016 - Mild cognitive impairment (MCI) is a slight but noticeable and measurable decline in cognitive abilities, such as remembering names or a list of items. While changes may not be severe enough to disrupt daily life, a clinical diagnosis of MCI indicates an increased risk of eventually developing Alzheimer’s disease or another type of dementia.

Artistic Skills Emerge as Dementia Progresses

July 28, 2016 - A new study by researchers at Neuroscience Research Australia (NeuRA) has identified the emergence of positive changes that occur after a person has been diagnosed with dementia.

Deep Brain Stimulation continues to show promise for patients with mild Alzheimer’s disease

July 21, 2016 - New findings published today by a team of researchers led by Dr. Andres Lozano at the Krembil Neuroscience Centre (KNC) of Toronto Western Hospital (TWH) have provided further insight into the effects of Deep Brain Stimulation (DBS) in the treatment of Alzheimer’s disease.

Special Issue of NeuroRehabilitation Investigates the Effectiveness of Treatment for Individuals with Brain Injury or Stroke

July 20, 2016 - In the current issue of NeuroRehabilitation leading researchers explore the effectiveness of several neurorehabilitation treatments for individuals with brain injury or stroke. A number of published articles have covered the issue of efficacy of neurorehabilitation, but only a few have discussed the issue of effectiveness.

Driving ability of people with cognitive impairment difficult to assess: research review

July 19, 2016 - No single assessment tool is able to consistently determine driving ability in people with Alzheimer’s disease and mild cognitive impairment, a St. Michael’s Hospital research review has found.

Mark W. Bondi, PhD, Recipient of 2016 Alzheimer Award

July 15, 2016 - The Journal of Alzheimer’s Disease (JAD) is pleased to announce that Mark W. Bondi, PhD, ABPP/CN, Professor of Psychiatry at UC San Diego and Director of the Neuropsychological Assessment Unit at the VA San Diego Healthcare System, has been chosen as the recipient of the 2016 Alzheimer Award presented by the journal in recognition of his outstanding work on the development of a novel and promising method of staging preclinical Alzheimer’s disease (AD) based on number of abnormal biomarkers that is predictive of progression to mild cognitive impairment (MCI) and AD.

Estrogen Patch in Newly Postmenopausal Women May Reduce Alzheimer’s Risk

July 14, 2016 - Can estrogen preserve brain function and decrease the risk of Alzheimer’s disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky plaques found in the brains of people with Alzheimer’s disease, a Mayo Clinic study published this month in the Journal of Alzheimer’s Disease found. Ultimately, these deposits harm neurons, leading to cognitive problems.

Leukemia Drug Shows Early Promise for Treating Parkinson’s Disease and Dementia

July 13, 2016 - Parkinson’s disease (PD) is the second most common neurodegenerative disorder that causes a range of motor and non-motor symptoms. During the course of the disease, dopamine (DA)-producing neurons are lost and bundles of proteins known as Lewy bodies (LBs) form in the brain. A study reported in the Journal of Parkinson’s Disease provided molecular evidence that the FDA-approved leukemia drug nilotinib may restore brain dopamine and reduce toxic proteins associated with LB formation in PD and dementia patients.

New Method to Grow and Transplant Muscle Stem Cells Holds Promise for Treatment of Muscular Dystrophy

June 28, 2016 - Satellite cells are stem cells found in skeletal muscles. While transplantation of such muscle stem cells can be a potent therapy for degenerative muscle diseases such as Duchenne muscular dystrophy, these cells tend to lose their transplantation efficiency when cultured in vitro. In a study in the current issue of the Journal of Neuromuscular Diseases, researchers treated these stem cells with leukemia inhibitory factor (LIF), which effectively maintained the undifferentiated state of the satellite cells and enhanced their transplantation efficiency.

Neurocentria Publishes Peer-Reviewed Paper Showing Mechanism of Action for Its Drug that Reverses Cognitive Impairment in Humans

June 14, 2016 - Neurocentria, Inc. announced today the publication of a scientific paper showing how its candidate drug, L­-Threonic acid Magnesium salt (L-TAMS), reverses cognitive impairment in humans, as previously demonstrated. The paper titled "Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration" was published in the medical journal Neuropharmacology. The drug's discovery is based on more than a decade of research at Stanford, Tsinghua University, and MIT.

Genetic Risk of Alzheimer’s Disease Associated with Changes in Brain Metabolism in Young Adults

May 30, 2016 - A team of investigators at Midwestern University, an affiliate institution of the Arizona Alzheimer’s Consortium, now report that young adult brain donors who carried a common genetic risk factor for Alzheimer’s disease showed large changes in pathways involving the uptake and use of sugars and ketone bodies — the primary sources of energy for the brain. The average age of the donors was approximately 30, well before any sign of the microscopic abnormalities commonly associated with the disease commonly appear, and almost five decades before the age at which they might develop symptoms.

Abnormally Low Blood Flow Indicates Damage to NFL Players’ Brains

April 26, 2016 - The discovery of brain pathology through autopsy in former National Football League (NFL) players called chronic traumatic encephalopathy (CTE) has raised substantial concern among players, medical professionals, and the general public about the impact of repetitive head trauma. Using sophisticated neuroimaging and analytics, researchers have now identified abnormal areas of low blood flow in living professional football players. These findings, published in the Journal of Alzheimer’s Disease, raises the potential for better diagnosis and treatment for persons with football related head trauma.

Simple Mind-Body Therapies Shown to Improve Subjective Cognitive Decline, a Pre-Clinical Stage of Alzheimer’s Disease

April 26, 2016 - Lead investigator Kim Innes, PhD, Associate Professor in the Department of Epidemiology in the WVU School of Public Health, and her team have published a new study in the Journal of Alzheimer’s Disease.

Problems finding your way around may be earliest sign of Alzheimer’s disease, study suggests

April 26, 2016 - Long before Alzheimer’s disease can be diagnosed clinically, increasing difficulties building cognitive maps of new surroundings may herald the eventual clinical onset of the disorder, finds new research from Washington University in St. Louis.

B-School Innovation Professor Discovers Pathway between Diabetes and Alzheimer’s Disease

April 12, 2016 - In a new paper published by The Journal of Alzheimer’s Disease, Professor Melissa Schilling, a strategy and innovation expert at the NYU Stern School of Business, uncovers a surprising new connection between diabetes and Alzheimer’s disease: hyperinsulinemia, which is most often caused by prediabetes, early or undiagnosed diabetes, or obesity, is responsible for almost half of all cases of Alzheimer’s disease.

Why do people with Alzheimer’s stop recognizing their loved ones?

April 12, 2016 - Alzheimer’s not only steals people’s memories but also their ability to recognize faces, which widens the gulf between people with this disease and their loved ones. A recent study has demonstrated that, beyond causing memory problems, Alzheimer’s disease also impairs visual face perception. This finding may help families better understand their loved one's inevitable difficulties and lead to new avenues to postpone this painful aspect of the disease. Research in this area by the team of Dr. Sven Joubert, PhD, a researcher at the Centre de recherche de l'Institut universitaire de gériatrie de Montréal of the CIUSSS du Centre-Sud-de-l’Île-de-Montréal and a professor with the Department of Psychology at Université de Montréal, has just been published in the Journal of Alzheimer’s Disease.

Researchers Identify Tissue Biomarker for Dementia with Lewy Bodies and Parkinson’s Disease

April 12, 2016 - Accurate diagnosis of Parkinson’s disease, and the related disease “dementia with Lewy bodies,” can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson’s Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.

New Neuroscience & Neurology Brochure Available

April 1, 2016 - Journals and Books

Parkinson’s Disease Funding Analyzer Launched on Journal of Parkinson’s Disease Website

March 31, 2016 - The Journal of Parkinson’s Disease (JPD) is proud to announce the launch of the Parkinson’s Disease Funding Analyzer (PDFA) on the JPD website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the Parkinson’s disease (PD) research community.

Are Stem-Cell Therapies for Parkinson’s Disease Ready for Clinical Trials?

March 29, 2016 - As stem cell-based therapies are moving rapidly towards clinical trials, treatments for Parkinson’s Disease (PD), an incurable condition, may be on the horizon. A recent announcement of a Phase I/IIa clinical trial involving transplantation of stem cells into the first human subjects has raised hope among patients and sparked discussions in the research community. In a commentary published in the Journal of Parkinson’s Disease, authors propose five key questions that should be addressed as this trial begins.

Infrequent home computer use may be indicative of early cognitive decline

March 22, 2016 - A new study sheds light on a powerful tool that may detect signs of Alzheimer’s disease before patients show any symptoms of cognitive decline: the home computer.

‘Slow thinking’ a conversation stopper for people with Parkinson’s

March 18, 2016 - Cognitive impairment could affect the conversational ability of people with Parkinson's more than physical speech problems - according to research from the University of East Anglia (UEA) and the University of Aberdeen.

A New Perspective on the Possible Cause of Alzheimer’s Disease: Microbes

March 17, 2016 - A landmark Editorial issued by 33 senior scientists and clinicians from a dozen countries across the world has been published in the highly regarded peer-reviewed journal, Journal of Alzheimer's Disease. This major call for action is based on substantial evidence indicating that some microbes – a specific virus and particular bacteria – are likely major causes of the disease.

Omega-3 fatty acids shown to exert a positive effect on the aging brain

March 17, 2016 - Researchers from Charité – Universitätsmedizin Berlin were able to show that omega-3 fatty acid supplementation improves memory function in humans. They studied the effects of supplementation with natural omega-3 fatty acids in healthy older adults over a period of six months. Results from the study, which show that supplementation leads to significant improvements in memory function, have been published in the current issue of the Journal of Alzheimer's Disease.

Some Ethnicities have a Greater Chance of Developing Alzheimer’s Disease before Age 65

March 15, 2016 - New study published in the Journal of Alzheimer’s Disease found that African Americans, Alaskans and Hawaiians are at greater risk for early-onset Alzheimer’s Disease.

Different Kinds of Physical Activity Shown to Improve Brain Volume and Cut Alzheimer’s Risk in Half

March 11, 2016 - A new study shows that a variety of physical activities from walking to gardening and dancing can improve brain volume and cut the risk of Alzheimer’s disease by 50%.

Depressive symptoms and the risk of Alzheimer’s disease in mild cognitive impairment

March 3, 2016 - According to a community-based longitudinal study in Japan, researchers found that depressive symptoms increased the risk of Alzhemer’s disease (AD) in an amnestic mild cognitive impairment (aMCI) group, but not in a non-amnestic mild cognitive impairment (naMCI) group. Likewise, depressive symptoms increased the risk of aMCI but not naMCI in a cognitively normal group. Depressive symptoms might be a clue to finding prodromal AD in patients with a certain type of MCI.

Dementia: “Illness” Label Can Lower Mood

March 3, 2016 - People who perceive dementia symptoms as an illness feel more negative than those who see it as an inevitable part of getting older, a new study indicates.

Stroke Patients’ Speech Loss Linked to Loss of Brain Interconnections

February 23, 2016 - When brain regions that control speech and reading comprehension are destroyed due to blockage of blood flow, patients are often unable to speak or comprehend spoken or written language. These difficulties with language, or “aphasia,” are a common symptom in the aftermath of stroke. However, in a new study published in Restorative Neurology and Neuroscience, researchers report that damage to the underlying connections among different areas of the brain can also affect the severity of aphasia.

Phase 2 Clinical Trial to Treat Rare Hereditary Muscle Disease Shows Promise

February 23, 2016 - Researchers present the first clinical study that provides evidence that an extended-release sialic acid supplement may stabilize muscle strength in patients with GNE myopathy (GNEM), a rare hereditary, progressive, adult-onset muscle disease.

Researchers Identify Biomarker for Early Cognitive Decline in Parkinson’s Disease Patients

February 17, 2016 - Many patients with Parkinson’s Disease (PD) develop mild cognitive impairment (MCI) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis of MCI and developing new cognitive-enhancing treatments. New research published in the Journal of Parkinson’s Disease indicates that lower concentrations of α-synuclein in cerebrospinal fluid (CSF) is associated with reduced performance on several cognitive tests.

Research discovers neuroprotective protein in blood is biomarker of Alzheimer’s disease

February 12, 2016 - Medical professionals have to conduct a long series of tests to assess a patient's memory impairment and cognitive skills, functional abilities, and behavioral changes to accurately diagnose Alzheimer's disease. They also have to execute costly brain imagining scans and even, sometimes, invasive cerebral spinal fluid tests to rule out other diseases. The process is laborious at best -- and subjective at worst.

Alzheimer Funding Analyzer Launched on Journal of Alzheimer’s Disease Website

February 11, 2016 - The Journal of Alzheimer’s Disease (JAD) is proud to announce the launch of the Alzheimer’s Funding Analyzer (AFA) on the JAD website. It is a free service that is part of a new suite of online features that have been designed to serve the needs of the Alzheimer disease (AD) research community.

Evidence of a lipid link in the inherited form of Alzheimer’s disease

February 9, 2016 - Australian researchers have found biochemical changes occurring in the blood, in the rare inherited form of Alzheimer’s disease. Changes in these fat-like substances, may suggest a method to diagnose all forms of Alzheimer’s disease before significant damage to the brain occurs.

Alzheimer’s Diagnosis Complicated by History of Reading Problems

January 21, 2016 - Correctly diagnosing Alzheimer’s disease remains a challenge for medical professionals. Now, a new study published in the current issue of the Journal of Alzheimer’s Disease reveals a new clue to possible misdiagnosis. The study found that older adults with a history of reading problems perform similarly on some neuropsychological tests to those who show signs of mild cognitive impairment (MCI) associated with early Alzheimer’s disease. The finding, based on the results of a Stony Brook University-led research team in collaboration with Boston University School of Medicine, emphasizes the need for professionals to take into account developmental history and have a broad understanding of neuropsychological testing when interpreting the meaning of low memory test scores.

Omega-3 levels affect whether B vitamins can slow brain’s decline

January 19, 2016 - While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins’ effect.

Mentally Challenging Activities Key to a Healthy Aging Mind

January 15, 2016 - One of the greatest challenges associated with the growing numbers of aged adults is how to maintain a healthy aging mind. Taking up a new mental challenge such as digital photography or quilting may help maintain cognitive vitality, say researchers reporting in Restorative Neurology and Neuroscience.

New Tool May Help Predict Patients’ Motor Function Recovery After Stroke

January 14, 2016 - Graph theoretical analysis is proving to be helpful in understanding complex networks in the brain. Investigators in the Republic of Korea used a graph theoretical approach in examining the changes in the configuration of the two hemispheres of the brain in 12 patients after stroke. They found it helped understand the dynamic reorganization of both hemispheric networks in the brain and to predict recovery of motor function. Their findings are published in Restorative Neurology and Neuroscience.

Researchers Face Potential Danger from Protein Particles in the Lab

January 8, 2016 - Lewy bodies and Lewy neurites are found in the brains of Parkinson’s disease (PD) patients. They consist primarily of fibrils of the protein alpha-synuclein (α-Syn), which self-assembles into fibrils in vitro. If introduced into the human body, these seeds can act as prions and trigger the formation of toxic protein deposits. Because α-Syn fibrils are often used in research, it is important that they are not accidentally transferred to humans or cell cultures. Researchers reporting in the Journal of Parkinson’s Disease describe three cleaning procedures that effectively remove and disassemble these α-synuclein seeds.

Study finds cerebrovascular disease to be major determinant of psychosis in patients with Alzheimer’s disease

January 8, 2016 - About half of all patients with Alzheimer’s disease develop symptoms of psychosis, such as delusions or hallucinations.

Use of Anticholinergic Drugs Does Not Increase Risk for Dementia in Parkinson’s Disease Patients

January 5, 2016 - Recent evidence has shown a greater risk of dementia, in particular Alzheimer’s disease (AD), in individuals using anticholinergic medications regularly. These drugs are widely used by older adults to treat bladder dysfunction, mood, and pain, and many of them are available without prescription. Since these drugs are often used to treat both motor symptoms and non-motor symptoms in patients with Parkinson’s Disease (PD), there is concern for increased risk of dementia. Contrary to expectations, a study in the current issue of the Journal of Parkinson’s Disease determined that the cognitive performance of PD patients taking anticholinergic medications did not differ from those who did not.

Link Between Anemia and Mild Cognitive Impairment

December 16, 2015 - In a large population-based study of randomly selected participants in Germany, researchers found that participants with anemia, defined as haemoglobin <13 g/dl in men and <12 g/dl in women, showed lower performances in verbal memory and executive functions. Furthermore, mild cognitive impairment (MCI) occurred almost twice more often in participants diagnosed with anemia. This study is published in the Journal of Alzheimer’s Disease.

Alzheimer’s disease progression linked to changing protein levels in immune system

December 16, 2015 - New research has identified changing levels of proteins in the blood which are associated with increasing mental impairment over time in people with Alzheimer's disease. The findings could ultimately help develop new drugs for the condition, by allowing better monitoring of the effects of drugs and improvements in clinical trials.

Early stage dementia patients referred to specialists are institutionalized twice as often as those who are not, according to new study in the Journal of Alzheimer’s Disease

December 10, 2015 - A new epidemiologic study showed that patients with early stage dementia, who had been referred to a specialist, have twice the risk of institutionalization compared to those who are not, according to a research study published in the Journal of Alzheimer’s Disease this month. The research suggested the influence of early specialist referral for dementia patients on institutionalization risk and demonstrated that the benefits of early dementia diagnosis may lead to challenging issues.

Singing is beneficial for memory and mood especially in early dementia

December 10, 2015 - Researchers led by Dr. Teppo Särkämö at University of Helsinki, Finland have revealed that caregiver-implemented musical leisure activities, particularly singing, are cognitively and emotionally beneficial especially in the early stages of dementia. The findings could help improve dementia care and better target the use of music in different stages of dementia. The research was published today in the Journal of Alzheimer's Disease.

Can Physical Exercise Enhance Long-Term Memory?

November 25, 2015 - Exercise can enhance the development of new brain cells in the adult brain, a process called adult neurogenesis. These newborn brain cells play an important role in learning and memory. A new study has determined that mice that spent time running on wheels not only developed twice the normal number of new neurons, but also showed an increased ability to distinguish new objects from familiar objects. These results are published in the first issue of Brain Plasticity, a new journal from IOS Press.

Reproductive history and risk of cognitive impairment in elderly women: a cross-sectional study in eastern China

November 12, 2015 - Researchers led by Professor Jun-Fen Lin at Zhejiang Provincial Center for Disease Control and Prevention have found that reproductive history, an important modifier of estrogen exposure across women’s lifetime, is associated with risk of cognitive impairment in postmenopausal women. These findings are published in the Journal of Alzheimer’s Disease.

Changes in humour may be an early sign of dementia

November 12, 2015 - Researchers at University College London (UCL) have revealed that a change in sense of humour could be an early sign of dementia. The findings could help improve dementia diagnosis, by highlighting changes not commonly thought to be linked to the condition. The study was funded by Alzheimer’s Research UK, the Wellcome Trust, Medical Research Council (MRC) and NIHR Queen Square Dementia Biomedical Research Unit. The research was published in the Journal of Alzheimer’s Disease on 10 November 2015.

No Increased Dementia Risk Found in Diagnosed Celiac Patients

November 11, 2015 - A new and comprehensive study by investigators at the Celiac Disease Center at Columbia University Medical Center has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.

Blood test detects pre-Alzheimer’s in Mexican-Americans with 96 percent accuracy

November 11, 2015 - A blood test developed at the University of North Texas Health Science Center detects pre-Alzheimer’s disease in asymptomatic Mexican-Americans with 96 percent accuracy.

Does Alcohol Consumption Affect the Risk for Parkinson’s Disease?

November 10, 2015 - For many years, researchers have been investigating whether there are any associations between Parkinson’s disease (PD) and lifestyle choices such as smoking and coffee and alcohol consumption. In a review published in the Journal of Parkinson’s Disease, the literature concerning alcohol consumption presents conflicting information.

Gaucher Disease May Protect Against Parkinson’s Disease-Related Color Visual Impairment

November 10, 2015 - Parkinson’s Disease (PD) patients have a five-fold greater risk of carrying genetic mutations in the β-glucocerebrosidase gene (GBA), which are commonly associated with Gaucher disease (GD). Patients with both PD and GD tend to experience earlier onset of PD and more serious cognitive changes than PD patients without the mutations. A new study published in the Journal of Parkinson’s Disease suggests that GD or the presence of GBA mutations may actually shield patients from deficiency in visual color discrimination, which is a hallmark of PD.

UCI study finds jet lag-like sleep disruptions spur Alzheimer’s memory, learning loss

November 3, 2015 - Chemical changes in brain cells caused by disturbances in the body’s day-night cycle may be a key underlying cause of the learning and memory loss associated with Alzheimer’s disease, according to a University of California, Irvine study.

Neurocentria’s Lead Compound MMFS-01 Improves Brain Age by 9 Years in Human Study on Older Adults

November 3, 2015 - Neurocentria Inc., a clinical-stage biopharmaceutical company developing therapeutics to enhance brain function and correct cognitive impairment, announced the successful completion of a human study demonstrating that the company’s lead compound significantly reversed cognitive impairment in subjects 50 to 70 years old. The results have been published in the peer-reviewed Journal of Alzheimer's Disease.

Use of benzodiazepines and related drugs common around Alzheimer’s diagnosis

October 22, 2015 - Benzodiazepines and related drugs are initiated frequently in persons with Alzheimer's disease already before the diagnosis, and their use becomes even more common after the diagnosis, shows a recent study from the University of Eastern Finland. Benzodiazepines and related drugs are used as a sleep medication and for anxiolytic purposes. These drugs were initiated more frequently in persons with Alzheimer's disease than in persons not diagnosed with AD. Compared to persons not diagnosed with AD, it was three times more likely for persons with Alzheimer's disease to initiate benzodiazepine use after the diagnosis, and benzodiazepines were most commonly initiated six months after the diagnosis.

Research Study Validates Neuroreader For Accurate And Fast Measurement Of Brain Volumes

October 21, 2015 - A new neuroimaging software, Neuroreader, was shown to be as accurate as traditional methods for detecting the slightest changes in brain volume, and does so in a fraction of the time, according to a research study published in the Journal of Alzheimer’s Disease this month. The research validates the software program that can be used for measuring hippocampal volume, a biomarker for detecting Alzheimer’s Disease.

Women with Alzheimer’s-related Gene Lose Weight More Sharply after Age 70 – Finding May Aid in the Treatment of Dementia

October 6, 2015 - Brooklyn, NY – Researchers led by Deborah Gustafson, PhD, MS, professor of neurology at SUNY Downstate Medical Center, have shown that women with a gene variant (APOEe4 allele) associated with Alzheimer’s disease experience a steeper decline in body mass index (BMI) after age 70 than those women without the version of the gene, whether they go on to develop dementia or not. The finding adds to a body of evidence suggesting that body weight change may aid in the diagnosis and management of Alzheimer's disease.

FSU Professors Conduct Study Showing Improved Memory for Patients with Mild Cognitive Impairment When Provided with “Nutraceutical Formulation”

September 24, 2015 - Framingham State Professor Ruth Remington, her colleague Tom Shea from UMass Lowell, and members of their research team, have published findings from a study that add to a growing body of evidence that lifestyle modification can help maintain brain power as we age.

Air pollution in Mexico City has detrimental impact on gene associated with Alzheimer’s disease, affecting parents and their children: New study

September 24, 2015 - A new study by researchers at the Universities of Montana, Valle de México, Boise State, and North Carolina, the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, and Centro Médico Cozumel heightens concerns over the detrimental impact of air pollution on hippocampal metabolites as early markers of neurodegeneration in young urbanites carrying an allele 4 of the apolipoprotein E gene (APOE). This is associated with the risk for Alzheimer disease (AD) and a susceptibility marker for poor outcome in traumatic brain injury (TBI) recovery. These findings are published in the Journal of Alzheimer’s Disease.

September 21, World Alzheimer’s Day – Identifying typical patterns in the progression towards Alzheimer’s disease

September 21, 2015 - How the brain progresses from mild cognitive impairment (MCI) to Alzheimer's-type dementia has been an enigma for the scientific community. However, a recent study by the team of Dr. Sylvie Belleville, PhD, Director of the Research Centre at the Institut universitaire de gériatrie de Montréal (Montreal Geriatric Institute) and Professor of Psychology at Université de Montréal, has shed light on this progression by showing the typical patterns of the brain's progression to dementia.

Researchers explore cocoa as novel dietary source for the prevention of cognitive deterioration in Alzheimer’s disease

September 15, 2015 - The potential benefits of dietary cocoa extract and/or its final product in the form of chocolate have been extensively investigated in regard to several aspects of human health. Cocoa extracts contain polyphenols, which are micronutrients that have many health benefits, including reducing age-related cognitive dysfunction and promoting healthy brain aging, among others.

Researchers shed light on potential shield from Alzheimer’s

September 10, 2015 - Today, more than 5.1 million Americans live with Alzheimer’s disease, a devastating type of dementia that plagues memory and thinking. That number is expected to triple in the coming decades. Moreover, according to a 2012 survey, Americans fear Alzheimer’s more than any other disease.

Magnetic Stimulation Effective in Helping Parkinson’s Patients Walk

September 1, 2015 - About 50% of patients with Parkinson’s disease (PD) experience freezing of gait (FOG), an inability to move forward while walking. This can affect not only mobility but also balance. In a new study published in Restorative Neurology and Neuroscience, researchers report that repetitive transcranial magnetic stimulation (rTMS) can reduce FOG and improve other motor skills in PD patients.

Mental Visual Imaging Training Improves Multiple Sclerosis Patients’ Well-Being

August 27, 2015 - Patients with relapsing-remitting multiple sclerosis (RR-MS), the most common form of the disease, often have deficits in two neuropsychological functions, autobiographical memory (AM) and episodic future thinking (EFT), which impact quality of life. In a new study published in Restorative Neurology and Neuroscience, researchers report that training RR-MS patients in mental visual imagery (MVI) can improve AM/EFT functioning.

Waterford research on Alzheimer’s disease suggests that measuring macular pigment offers potential as a biomarker of cognitive health

August 25, 2015 - Ongoing European Research Council-funded research at Waterford Institute of Technology’s (WIT) Macular Pigment Research Group (MPRG) is investigating the potential link between cognitive function and levels of a vital eye pigment linked to diet. The study suggests that measuring macular pigment offers potential as a biomarker of cognitive health. The results of this study are highlighted to a global audience through the prestigious international medical journal, the Journal of Alzheimer’s Disease.

New Study Indicates Magnetic Stimulation Effective in Reducing Bedwetting

August 25, 2015 - Bedwetting, or nocturnal enuresis, causes distress in children and young adults, as well as for their parents or caregivers. The causes are not fully understood and there may be both physiological and psychological components to the condition. In a new study published in Restorative Neurology and Neuroscience, researchers report that repetitive sacral root magnetic stimulation (rSMS) can reduce the frequency of nighttime bedwetting and improve quality-of-life for sufferers.

Insulin’s potential to treat dementia outlined in new study

August 6, 2015 - Researchers at the UW Medicine, Veteran's Administration Puget Sound and Saint Louis University have made a promising discovery that insulin delivered high up in the nasal cavity goes to affected areas of brain with lasting results in improving memory.

Coffee Consumption Habits Impact the Risk of Mild Cognitive Impairment: The Italian Longitudinal Study on Aging

July 29, 2015 - A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS “Casa Sollievo della Sofferenza”, San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di Sanità (ISS), Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based sample from eight Italian municipalities with a 3.5-year median follow-up. These findings are published in the Journal of Alzheimer’s Disease.

Alzheimer’s Disease Prevention: New Journal Article Highlights Benefits of Meditation and Spiritual Fitness

July 27, 2015 - Meditation and spiritual fitness are key components in reducing the risk of Alzheimer’s disease according to a new article, “Stress, Meditation, and Alzheimer’s Prevention: Where the Evidence Stands”, published in an early online version of the Journal of Alzheimer’s Disease 48(1). The print edition is scheduled to be published in August.

New Study Indicates Ankle-Brachial Index Associated with Mild Cognitive Impairment

July 23, 2015 - In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment (MCI) occurred significantly more often in individuals diagnosed with a lower ankle brachial index (ABI), which is a marker of generalized atherosclerosis and thus cumulative exposure to cardiovascular risk factors during lifetime. Interestingly, this strong association was only observed in patients with non-amnestic MCI, but not amnestic MCI. There also was no independent association of MCI and intima media thickness (IMT) or coronary artery calcification (CAC), two other surrogate markers of cardiovascular risk. Examination of differences by gender revealed a stronger association of a decreasing ABI with non-amnestic MCI in women. This study is published in the Journal of Alzheimer’s Disease.

Midlife High Blood Pressure May Negatively Impact the Brain Years Later

July 17, 2015 - Having high blood pressure in your 50’s may impact your ability to keep track or plan ahead in your 80’s.

Affordable, Non-Invasive Test May Detect Who is Most at Risk for Alzheimer’s

July 17, 2015 - Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer’s disease. Although no conclusive test exists to predict who will develop Alzheimer’s, new research from the Center for BrainHealth at The University of Texas at Dallas is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk.

Multiple Pathways Progressing to Alzheimer’s Disease

June 30, 2015 - The amyloid cascade hypothesis of Alzheimer’s disease (AD) posits that sticky aggregations or plaques of amyloid-beta peptides accumulate over time in the brain, triggering a series of events that ultimately result in the full-blown neurodegenerative disorder. The hypothesis has been a major driver of AD research for more than 20 years.

Hartmuth Kolb, PhD, Wins 2015 Alzheimer Award

June 26, 2015 - The Journal of Alzheimer’s Disease is proud to announce that Hartmuth Kolb, PhD, Head of Neuroscience Biomarkers, Johnson & Johnson, San Diego, CA, has been chosen as the recipient of the 2015 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on the importance and imaging of neurofibrillary tangles (NFTs) and Alzheimer’s disease (AD).

New Study Calls for Partnering of Parkinson’s Disease Research Community with Patient Groups to Improve Effectiveness of Clinical Trials

June 25, 2015 - Despite an urgent need for new medications, clinical trials in Parkinson’s disease (PD) have a relatively low rate of success. The reasons for this are complex, prompting a group of investigators from PD advocacy groups to conduct a survey of the principle stakeholders, PD scientists, patients, and caregivers, to determine some of the underlying barriers. Their results are published in the Journal of Parkinson’s Disease.

What Is the Role of the Gut Microbiome in Developing Parkinson’s Disease?

June 24, 2015 - In recent years, an important Parkinson’s disease (PD) research focus has been on gut-related pathology, pathophysiology, and symptoms. Gastrointestinal dysfunction, in particular constipation, affects up to 80% of PD patients and idiopathic constipation is one of the strongest risk-factors for PD. Lifestyle factors such as smoking and coffee consumption, as well as blood urate levels, have been associated with a decreased PD risk. These factors may also be influenced by the bacteria living in the human gut mediating the effects of various chemicals and nutrients on disease processes. In a contribution in the current issue of the Journal of Parkinson’s Disease, researchers review some of the latest studies linking gut microbiota to PD.

Researchers Develop New Technique for Modeling Neuronal Connectivity Using Stem Cells

June 17, 2015 - Human stem cells can be differentiated to produce other cell types, such as organ cells, skin cells, or brain cells. While organ cells, for example, can function in isolation, brain cells require synapses, or connectors, between cells and between regions of the brain. In a new study published in Restorative Neurology and Neuroscience, researchers report successfully growing multiple brain structures and forming connections between them in vitro, in a single culture vessel, for the first time.

Anti-rejection medications for transplant recipients protect against Alzheimer’s disease

June 11, 2015 - A new study from The University of Texas Medical Branch at Galveston has revealed that a treatment taken daily by people who have had organ transplants to prevent organ rejection protects against Alzheimer’s disease. An early online version of this paper detailing the findings has been published and is scheduled for publication in the July 7 issue of the Journal of Alzheimer’s Disease.

Dementia found to decrease sexual activity

May 26, 2015 - In a new study published in the Journal of Alzheimer’s Disease, Dr Rebekah Ahmed and colleagues found that patients with dementia show a decrease in sexual relations with their partners.

Green Tea Extract and Exercise Hinder Progress of Alzheimer’s Disease in Mice

May 6, 2015 - According to the National Institutes of Health (NIH), Alzheimer’s disease (AD) may affect as many as 5.5 million Americans. Scientists currently are seeking treatments and therapies found in common foods that will help stave off the disease or prevent it completely. Now, University of Missouri researchers have determined that a compound found in green tea, and voluntary exercise, slows the progression of the disease in mice and may reverse its effects. Further study of the commonly found extract could lead to advancements in the treatment and prevention of Alzheimer’s disease in humans.

Waterford researchers find link between Alzheimer’s disease and impaired vision arising from nutrient deficiency

April 14, 2015 - A team from the Vision Research Centre at Waterford Institute of Technology has discovered that patients with Alzheimer’s disease have significantly worse vision than others in their age group and are more likely to be seriously deficient in carotenoids, key nutrients in the eye.

York U Alzheimer’s study on women at risk suggests functional decline relates to deteriorating brain wiring

April 2, 2015 - In their latest brain imaging study on women at risk for Alzheimer’s disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer.

Severe Alzheimer’s Patient Responds to Bryostatin Treatment

April 2, 2015 - Researchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) and the Marshall University Joan C. Edwards School of Medicine announced their findings from a new study entitled, "PSEN1 Variant in a Family with Atypical AD." An Alzheimer patient with very severe disease, genetically confirmed to have a known variant of PSEN1, showed promising benefits during treatment with the drug Bryostatin 1. Genetically confirmed Alzheimer’s patients as severely advanced as patient IV-18 have not shown this level of clinical improvement previously with other treatment(s).

Surprising finding provides more support for Alzheimer’s being an autoimmune disease

March 10, 2015 - Brain levels of the lipid ceramide are high in Alzheimer’s disease, and now scientists have found increased levels of an antibody to the lipid in their disease model.

Follow IOS Press on Facebook

March 3, 2015 - We are pleased to inform you that IOS Press now has its own Facebook page:

Levodopa-Carbidopa Intestinal Gel May Prove More Effective for Long-Term Treatment of Parkinson’s Disease than Standard Levodopa

February 27, 2015 - Although levodopa remains the “gold standard” to effectively control motor deficits in the treatment of early stage Parkinson’s disease (PD), it loses effectiveness as the disease progresses. After four to six years of treatment with oral medications for Parkinson’s disease, about 40% of patients experience lack of muscle control (dyskinesias), end-of-dose wearing off, and fluctuations in “On/Off” states. By nine years of treatment, about 90% will suffer these effects.

Cardiac and Respiratory Function Supported by Abdominal Muscles in Muscular Dystrophy

February 27, 2015 - The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy (MD) can also lead to decreased function of specific muscles involved in respiration causing breathing difficulties as well as leading to cardiac problems.

Parkinson’s Disease Patients Have Reduced Visual Contrast Acuity

February 26, 2015 - Patients with Parkinson’s disease (PD) often have difficulties with visual acuity in low-contrast images. Because they may have normal high-contrast vision, this is often overlooked during routine eye exams. In the current issue of the Journal of Parkinson’s Disease, researchers report that PD patients had significantly worse vision for low-contrast images at close (40 cm) and far (2 m) distances. Even for high-contrast images, PD patients’ vision was deficient at far distances.

Use of the International Classification of Functioning, Disability and Health (ICF) Benefits Neurorehabilitation Research and Patient Care

February 25, 2015 - Use of the International Classification of Functioning, Disability and Health (ICF) has increased significantly over the last decade. The current issue of NeuroRehabilitation features a series of insightful articles that provide examples of how the ICF can be successfully implemented in clinical practice and research related to neurorehabilitation, ultimately benefiting patient care.

2015 Neuroscience & Neurology brochure available

February 18, 2015 - IOS Press Neuroscience & Neurology brochure

Decreases in Short-Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution

February 3, 2015 - A new study by researchers at the Universities of Montana, Carleton, and North Carolina, and the Centro de Ciencias de la Atmósfera, Universidad Nacional Autónoma de México, heightens concerns over the detrimental impact of the apolipoprotein E (APOE) ε4 allele -- the most prevalent genetic risk for Alzheimer’s disease -- upon cognition, olfaction, and metabolic brain indices in healthy urban children and teens. These findings are published in the Journal of Alzheimer’s Disease.

New study postulates the role of dietary advanced glycation end products in the risk of Alzheimer’s disease

February 3, 2015 - New paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.

Prostate cancer drug slows memory loss in women with Alzheimer’s disease

January 22, 2015 - Women with Alzheimer’s disease showed stable cognition for a year when a drug that is more commonly used to treat advanced prostate cancer was added to their drug regimen, according to a new study from researchers at the University of Wisconsin-Madison.

First Evidence of Potential Efficacy of Tau Aggregation Inhibitor Therapy in Alzheimer’s Disease

January 20, 2015 - The Journal of Alzheimer’s Disease has published today the results of the first clinical trial of a Tau Aggregation Inhibitor (TAI) in Alzheimer’s disease (AD).1 This Phase II clinical trial, conducted by TauRx Therapeutics Ltd (a Singapore incorporated spinout from the University of Aberdeen), provided the basis and rationale for subsequent Phase III clinical trials of a TAI in AD currently in progress.

A virtual reality brain training game can detect mild cognitive impairment (MCI), a condition that often predates Alzheimer’s disease (AD)

January 13, 2015 - Greek researchers demonstrated the potential of a virtual supermarket cognitive training game as a screening tool for patients with mild cognitive impairment (MCI) among a sample of older adults. MCI is a condition that often predates Alzheimer’s disease (AD) and is characterized by memory loss and inability to execute complex activities such as financial planning.

Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer’s Dementia

January 9, 2015 - A man-made form of insulin delivered by nasal spray may improve working memory and other mental capabilities in adults with mild cognitive impairment and Alzheimer’s disease dementia, according to a pilot study led by researchers at Wake Forest Baptist Medical Center.

Running and walking may lower Alzheimer’s Disease risk

December 16, 2014 - An estimated 5 million Americans aged 65 and older have Alzheimer’s disease. As drug companies struggle to find a cure, new research from the National Runners’ and Walkers’ Health Study suggests that exercise earlier in life may substantially reduce Alzheimer’s disease mortality. The study, which appeared in an online prepublication from the Journal of Alzheimer’s Disease, involved over 154,000 runners and walkers who were followed for 11.6 years. There were 175 deaths where Alzheimer’s disease was diagnosed as an underlying or contributing cause of death during follow-up.

Patient Awakes from Post-Traumatic Minimally Conscious State after Administration of Depressant Drug

December 16, 2014 - A patient who had suffered a traumatic brain injury unexpectedly recovered full consciousness after the administration of midazolam, a mild depressant drug of the GABA A agonists family. This resulted in the first recorded case of an “awakening” from a minimally-conscious state (MCS) using this therapy. Although similar awakenings have been reported using other drugs, this dramatic result was unanticipated. It is reported in Restorative Neurology and Neuroscience.

Better Detection, Prevention, and Pre-Clinical Treatment: Three Effective Tools in the Fight Against Alzheimer’s Disease

December 5, 2014 - Detection, prevention, and preclinical treatment are three key areas that may make a difference in the battle to reduce the rapid rise of new Alzheimer’s disease (AD) cases every year. These three topics are the focus of an important new supplement to the Journal of Alzheimer’s Disease.

Mind before matter: do negative thoughts increase risk of Alzheimer’s disease?

November 19, 2014 - Researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London have proposed that repetitive negative thinking (RNT), a common symptom of many psychological disorders, may increase the risk of developing Alzheimer’s disease.

Simple Clinical Tests Help Differentiate Parkinson’s Disease from Atypical Parkinsonism

November 18, 2014 - Two simple tests conducted during the neurological exam can help clinicians differentiate between early-stage Parkinson’s disease (PD) and atypical parkinsonism. By asking patients to perform a tandem gait test and inquiring whether they are still able to ride a bicycle, clinicians can ascertain whether medio-lateral balance is impaired, a defining characteristic of atypical parkinsonism. These findings are published in the Journal of Parkinson’s Disease.

New Research on Walnuts and the Fight Against Alzheimer’s Disease

October 22, 2014 - A new animal study published in the Journal of Alzheimer’s Disease indicates that a diet including walnuts may have a beneficial effect in reducing the risk, delaying the onset, slowing the progression of, or preventing Alzheimer’s disease.

User-Friendly Electronic “EyeCane” Enhances Navigational Abilities for the Blind

October 21, 2014 - White Canes provide low-tech assistance to the visually impaired, but some blind people object to their use because they are cumbersome, fail to detect elevated obstacles, or require long training periods to master. Electronic travel aids (ETAs) have the potential to improve navigation for the blind, but early versions had disadvantages that limited widespread adoption. A new ETA, the “EyeCane,” developed by a team of researchers at The Hebrew University of Jerusalem, expands the world of its users, allowing them to better estimate distance, navigate their environment, and avoid obstacles, according to a new study published in Restorative Neurology and Neuroscience.

People at high risk of Alzheimer’s may have early visuomotor difficulties

October 8, 2014 - Before there are any telltale behavioural signs of dementia, a simple test that combines thinking and movement could point to those with a heightened risk of developing Alzheimer’s disease and who are already having visuomotor difficulties, according to new research out of York University.

UB researchers corroborate the neuroprotective effects of Sirtuin 1 activation on mice with Alzheimer’s disease

October 7, 2014 - A study coordinated by the University of Barcelona (UB) has described a mechanism that plays a key role in the evolution of Alzheimer’s disease. According to the paper published in the Journal of Alzheimer’s Disease, the activation of the protein Sirtuin 1 in a murine model with familial Alzheimer’s disease has neuroprotective effects. The study, based on the PhD thesis developed by the researcher David Porquet (UB), first describes Sirtuin 1 pathway in this murine model. Mercè Pallàs, from the Department of Pharmacology and Therapeutic Chemistry at the Faculty of Pharmacy of UB, coordinates the study. The Bellvitge Biomedical Research Institute (IDIBELL) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) also collaborate in the study.

Marijuana compound may offer treatment for Alzheimer’s disease, University of South Florida preclinical study indicates

September 30, 2014 - Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows.

Conversion of mild cognitive impairment to dementia among subjects with diabetes

September 17, 2014 - Findings by researchers at the School of Public Health of Tianjin Medical University suggest that in a survival analysis of the cohorts, Type 2 diabetes mellitus with mild cognitive impairment (T2DM-MCI) accelerated the median progression to dementia by 2.74 years.

Study Finds Air Pollution Harmful to Young Brains

September 17, 2014 - Pollution in many cities threatens the brain development in children. Findings by University of Montana Professor Dr. Lilian Calderón-Garcidueñas, MA, MD, Ph.D., and her team of researchers reveal that children living in megacities are at increased risk for brain inflammation and neurodegenerative changes, including Alzheimer’s or Parkinson’s disease.

Few Mild-to-Moderate PD Patients Suffer from Malnutrition, Yet Almost One Third Are at Risk

September 11, 2014 - Patients with Parkinson’s disease (PD) can experience difficulties with food preparation and ingestion, which could contribute to poor nutrition and place them at risk for malnourishment. Published studies have also suggested that PD is associated with low weight, however, few studies included control groups. A report published in the Journal of Parkinson’s Disease counters this conclusion in patients with mild-to-moderate PD, finding that the incidence or risk of malnutrition is no different for patients with mild-to-moderate PD compared to healthy controls.

Diabetes Mellitus and Mild Cognitive Impairment: Higher Risk in Middle Age?

September 3, 2014 - Essen, Germany, September 2, 2014 – In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment (MCI) occurred twice more often in individuals diagnosed with diabetes mellitus type 2. Interestingly, this strong association was only observed in middle-aged participants (50-65 years), whereas in older participants (66-80 years) the association vanished. This study is published in the Journal of Alzheimer’s Disease.

Marijuana compound may offer treatment for Alzheimer’s disease

September 1, 2014 - Tampa, FL -- Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows.

Computerized Cognition Test Provides Better Assessment than Observation

August 28, 2014 - Research published in the Journal of Alzheimer’s Disease this week suggests healthy older adults are less capable of observing their own cognitive decline over an 18 month period than Cogstate’s computerized brief battery (CBB). The study, conducted by neuropsychologists, also indicated that close family members were unable to perceive decline in the cognitive behavior of their partner and trial participant in social settings.

Conflicts with Teachers Are Risk Factor for School Shootings

August 27, 2014 - As part of the TARGET project funded by the German Federal Ministry of Education and Research, researchers at Freie Universität Berlin conducted a systematic literature search of all the available studies dealing with school shootings. The aim of the analysis was to clarify which social dynamics in the social network of perpetrators can be observed in advance as playing an important role in school shootings. Up to now, researchers had assumed that bullying between peers and the social exclusion of the perpetrators were the most prominent factors in school shootings. This study shows, however, that in many cases conflicts with teachers seemed to be a decisive factor in the school shooting cases investigated.

Human Brain Deficits of PKCe: Targeted for Alzheimer’s Disease Therapeutic and Diagnostic Trials

August 20, 2014 - Today, researchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) announced findings from a new study entitled, “PKCe Deficits in Alzheimer’s Disease Brains and Skin Fibroblasts.” These new findings offer significant promise for a new therapeutic and diagnostic approach to Alzheimer's disease (AD) that has remained so refractory to effective and early drug treatment. This approach is now the major focus of ongoing clinical trials being conducted by at BRNI/Neurotrope, Inc. collaboration. In contrast to past strategies, this new therapeutic strategy now being clinically tested, not only removes the precursors to amyloid plaques and tangles, it also induces the growth of new synapses and prevents neuronal death.

Drexel University College of Medicine Research May Lead to Improved Alzheimer’s/ Vascular Dementia Diagnostic Guidelines

August 14, 2014 - Alzheimer’s disease (AD) and vascular dementia (VaD) are the most common forms of dementia. Traditionally, these illnesses have been treated as separate clinical syndromes. But new research led by Drexel University College of Medicine suggests that AD and VaD have much more in common than diagnostic guidelines currently allow. The study is set for publication in the September edition of the Journal of Alzheimer’s Disease.

Decline in Daily Functioning Related to Decreased Brain Activity in Early Stages of Alzheimer’s Disease

August 12, 2014 - Decline in daily functioning associated with Alzheimer’s disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer’s Disease.

Dementia Risk Quadrupled in People with Mild Cognitive Impairment

August 7, 2014 - In a long-term, large-scale population-based study of individuals aged 55 years or older in the general population researchers found that those diagnosed with mild cognitive impairment (MCI) had a four-fold increased risk of developing dementia or Alzheimer’s disease (AD) compared to cognitively healthy individuals. Several risk factors including older age, positive APOE-ɛ4 status, low total cholesterol levels, and stroke, as well as specific MRI findings were associated with an increased risk of developing MCI. The results are published in a supplement to the Journal of Alzheimer’s Disease.

JAD Leads the Field in New Study of More Than 6 Decades of AD Literature

August 6, 2014 - There have been several studies mapping out Alzheimer’s disease (AD) research using bibliometrics. One of these studies was instrumental in building the Top 100 Most Prolific AD Investigators and Top 100 Most Cited AD Investigators lists that you’ll find on the JAD website.

Study disproves link between lyme disease and alzheimer’s

July 18, 2014 - New research from the University of Toronto Mississauga definitively puts to rest a theory that Lyme disease causes Alzheimer’s.

Symptoms of depression predict dementia

July 17, 2014 - People who develop a combination of mild cognitive problems and depressive symptoms in old age are more likely to develop Alzheimer’s than are their age peers with mild cognitive disorders and no symptoms of depression. This was the conclusion of a study conducted at the University of Antwerp, in which scientists followed a large group of elderly people with mild cognitive impairment. The study is appearing in a leading publication, the Journal of Alzheimer’s Disease.

Sleep Disturbances, Common in Parkinson’s Disease, Can Be Early Indicator of Disease Onset

July 11, 2014 - Up to 70% of Parkinson’s disease (PD) patients experience sleep problems that negatively impact their quality of life. Some patients have disturbed sleep/wake patterns such as difficulty falling asleep or staying asleep, while other patients may be subject to sudden and involuntary daytime sleep “attacks.” In the extreme, PD patients may exhibit REM-sleep behavior disorder (RBD), characterized by vivid, violent dreams or dream re-enactment, even before motor symptoms appear. A review in the Journal of Parkinson’s Disease discusses the underlying causes of sleep problems in PD, as well as medications, disease pathology, and comorbidities, and describes the most appropriate diagnostic tools and treatment options.

Deep Brain Stimulation Improves Non Motor Symptoms in Parkinson’s Disease as well as Motor Symptoms

July 3, 2014 - Deep brain stimulation (DBS) has become a well-recognized non-pharmacologic treatment that improves motor symptoms of patients with early and advanced Parkinson’s disease. Evidence now indicates that DBS can decrease the number and severity of non motor symptoms of patients with Parkinson’s disease (PD) as well, according to a review published in the Journal of Parkinson’s Disease.

New Insights for Coping With Personality Changes in Acquired Brain Injury

July 2, 2014 - Individuals with brain injury and their families often struggle to accept the associated personality changes. The behavior of individuals with acquired brain injury (ABI) is typically associated with problems such as aggression, agitation, non-compliance, and depression. Treatment goals often focus on changing the individual’s behavior, frequently using consequence-based procedures or medication. In the current issue of NeuroRehabilitation leading researchers challenge this approach and recommend moving emphasis from dysfunction to competence.

Cocoa Extract May Counter Specific Mechanisms of Alzheimer’s Disease

June 25, 2014 - A specific preparation of cocoa-extract called Lavado may reduce damage to nerve pathways seen in Alzheimer’s disease patients’ brains long before they develop symptoms, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published June 20 in the Journal of Alzheimer’s Disease (JAD).

Researchers Identify Mitochondrial Mutation Linked to Congenital Myasthenic Syndrome

June 24, 2014 - Although significant progress has been made over the last 25 years to identify genetic abnormalities associated with congenital myasthenic syndromes (CMS), many patients remain genetically undiagnosed. A report in the inaugural issue of the Journal of Neuromuscular Diseases identifies a gene defect in mitochondria, specifically the citrate carrier SLC25A1, that may underlie deficits in neuromuscular transmission seen in two siblings.

Bob Olsson, PhD, Wins 2014 Alzheimer Award

May 28, 2014 - We are proud to announce that Bob Olsson, PhD, has been chosen as the recipient of the 2014 Alzheimer Award presented by the Journal of Alzheimer’s Disease in recognition of his outstanding work on microglia markers and Alzheimer’s disease.

Compound Reverses Symptoms of Alzheimer’s Disease in Mice, SLU Research Shows

May 21, 2014 - A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer’s disease, according to findings in the May issue of the Journal of Alzheimer’s Disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory.

Exenatide Has Potential as a Disease Modifying Agent in Parkinson’s Disease

May 6, 2014 - A follow-up study of patients with Parkinson’s disease (PD) who participated in an earlier “proof of concept” clinical trial using...

Study: Testosterone therapy can damage brain health in Caucasian men

May 6, 2014 - Ads touting testosterone replacement therapy are ubiquitous on radio and television. But medical research has determined that its success at enhancing libido may come at a price.

No Evidence of AD-Associated Changes in Adolescents Carrying Genetic Risk Factors

April 9, 2014 - Two studies published in the Journal of Alzheimer’s Disease indicate that some of the pathologic changes associated with Alzheimer’s disease in older individuals are not apparent in young people who carry the apolipoprotein (APOE) genetic risk factor for developing the disease. In the first study, no differences were found in hippocampal volume or asymmetry between cognitively normal adolescent carriers and non-carriers of the ApoE ɛ4 or ɛ2 allelles. The second study reports no differences in plasma concentrations of amyloid-β peptides among young adult ɛ4, ɛ3 or ɛ2 carriers.

New Therapeutic Target Discovered for Alzheimer’s Disease

March 19, 2014 - A team of scientists from the University of California, San Diego School of Medicine, the Medical University of South Carolina and San Diego-based American Life Science Pharmaceuticals, Inc., report that cathepsin B gene knockout or its reduction by an enzyme inhibitor blocks creation of key neurotoxic pGlu-Aβ peptides linked to Alzheimer’s disease (AD). Moreover, the candidate inhibitor drug has been shown to be safe in humans.

SDSC/UC San Diego Researchers Hone in on Alzheimer’s Disease

February 21, 2014 - Researchers studying peptides using the Gordon supercomputer at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego (UCSD) have found new ways to elucidate the creation of the toxic oligomers associated with Alzheimer’s disease.

Neuropsychological assessment more efficient than MRI for tracking disease progression in memory clinic patients

February 19, 2014 - Investigators at the University of Amsterdam, The Netherlands, have shown that progression of disease in memory clinic patients can be tracked efficiently with 45 minutes of neuropsychological testing. MRI measures of brain atrophy were shown to be less reliable to pick up changes in the same patients.

EyeMusic Sensory Substitution Device Enables the Blind to “See” Colors and Shapes

February 5, 2014 - Using auditory or tactile stimulation, Sensory Substitution Devices (SSDs) provide representations of visual information and can help the blind “see” colors and shapes. SSDs scan images and transform the information into audio or touch signals that users are trained to understand, enabling them to recognize the image without seeing it.

The Art and Science of Cognitive Rehabilitation Therapy

February 4, 2014 - There is a growing need for Cognitive Rehabilitation Therapy (CRT) due to the huge influx of soldiers returning from war zones with brain injuries, athletes with sports-related head injuries, and the growing population with age-related cognitive decline. This special collection of articles in NeuroRehabilitation illustrates the art and science of restoring mental functioning in those who have suffered a debilitating injury or who may otherwise have problems with attention, comprehension, learning, remembering, problem solving, reasoning, and processing.

2014 Neuroscience Neurology Brochure

January 31, 2014 - Download the 2014 Neuroscience Neurology Brochure here.

Real-Time Video Feedback Could Improve Effect of Core Stabilization Exercise in Stroke Patients

January 31, 2014 - About 80% of stroke survivors experience hemiparesis, which causes weakness or the inability to move one side of the body. Core stabilization exercise to improve postural stability and independent walking in chronic hemiparetic stroke patients could be enhanced by real-time video feedback, report researchers in Restorative Neurology and Neuroscience.

Higher Vitamin D Levels Associated with Better Cognition and Mood in Parkinson’s Disease Patients

January 17, 2014 - A new study exploring vitamin D levels in patients with Parkinson’s disease (PD) opens up the possibility of a new avenue of early intervention that may delay or prevent the onset of cognitive impairment and depression. The findings are published in the Journal of Parkinson’s Disease.

New Research Suggests Changes in Parietal Brain Gray Matter Volume Associated with Memory Deficits in Early PD

January 17, 2014 - Research by a team of investigators in Finland suggests that the free recall memory deficits common even in early stages Parkinson’s disease (PD) are related to structural changes in the brain, specifically parietal cortical gray matter volume. Their findings are published in the current issue of the Journal of Parkinson’s Disease.

Residual Activity “Hot Spots” in the Brain Key for Vision Recovery in Stroke Patients

January 3, 2014 - Scientists know that vision restoration training (VRT) can help patients who have lost part of their vision due to glaucoma, optic nerve damage, or stroke regain some of their lost visual functions, but they do not understand what factors determine how much visual recovery is achieved.

Study Reveals Buildup of Amyloid in Brain Blood Vessels Promotes Early Cognitive Impairment

January 2, 2014 - A team of Stony Brook University researchers led by William Van Nostrand, PhD, Professor in the Department of Neurosurgery, has discovered in a model of Alzheimer’s disease that early accumulation of a small protein, known as amyloid β, in the blood vessels of the brain can drive early cognitive impairment. The findings, published in the current online edition of the Journal of Alzheimer’s Disease, suggest that targeting early buildup of amyloid in brain blood vessels could be a potential treatment strategy in early stage disease.

Lifestyle holds key to predicting women’s brain health

December 19, 2013 - Australian researchers have identified lifestyle factors that impair women’s brain performance as early as age 45.

A research team finds a method to predict Alzheimer’s disease within two years of screening

December 3, 2013 - At the first signs of memory loss, most people start worrying and wonder, “What if I have Alzheimer's disease?” And yet, the disease is often diagnosed late in its development and sometimes up to ten years after the first pathological changes have affected the brain. A major goal in the treatment of Alzheimer's disease has been to provide earlier diagnosis so that patients can receive treatment as early as possible. A study by Sylvie Belleville, PhD, Director of Research at the Institut universitaire de gériatrie de Montréal, an institution affiliated with Université de Montréal, has shown a way to do just that. In their study, Sylvie Belleville and her team accurately predicted (at a rate of 90%) which of their research subjects with mild cognitive impairment would receive a clinical diagnosis of Alzheimer's disease within the following two years and which subjects would not develop this disease. The study was published in Volume 38, Issue 2 of the prestigious Journal of Alzheimer's Disease.

Corticosteroid Added to Standard Treatment Improves Eyesight in Patients with Sudden Vision Loss

November 20, 2013 - Nonarteritic anterior ischemic optic neuropathy (NAION) is one of the leading causes of sudden and irreversible loss of vision in older adults. In a prospective randomized trial of 60 patients with NAION, investigators have shown that the addition of the corticosteroid fluocortolone (FC) to standard therapy significantly improves both short- and long-term visual acuity, especially when given soon after the onset of symptoms. Their results are published in Restorative Neurology and Neuroscience.

Prescription of anti-Alzheimer medications to persons with mild cognitive impairment (MCI) is low in France

November 15, 2013 - In France prescription of drugs for Alzheimer’s disease (AD) is strictly regulated. The Department of Public Health and the Memory Clinic of Nice University Hospital have explored real world prescriptions of anti-AD medications in patients with mild cognitive impairment (MCI) not AD. A national survey [1] was set up from the data of the French National Alzheimer Databank (BNA) and shows that off label prescriptions are not frequent and concern 6.1% of MCI patients (versus a quarter of MCI patients in the US [2]). French physicians seem to limit this kind of prescription to MCI patients at risk of conversion to AD: more aged, with a more important quantitative cognitive impairment and with a memory predominant form. In a context of low efficacy of the available medications against AD this study emphasizes the need to develop more preventive drugs.

New Method Predicts Time from Alzheimer’s Onset to Nursing Home, Death

November 8, 2013 - A Columbia University Medical Center-led research team has clinically validated a new method for predicting time to full-time care, nursing home residence, or death for patients with Alzheimer’s disease. The method, which uses data gathered from a single patient visit, is based on a complex model of Alzheimer’s disease progression that the researchers developed by consecutively following two sets of Alzheimer’s patients for 10 years each. The results were published online ahead of print in the Journal of Alzheimer's Disease.

Sanders-Brown Researchers Produce New Research on Little-Understood Brain Disease

November 8, 2013 - As the population of older adults continues to grow, researchers at the University of Kentucky Sanders-Brown Center on Aging are engaged in work to understand the mechanisms of a variety of diseases that predominately affect those of advanced age.

New Study Links Depression in Newly Diagnosed Parkinson’s Disease Patients to Reduced Striatal Dopamine Synthesis

October 10, 2013 - According to the Parkinson’s Disease Foundation, up to 60% of individuals with Parkinson’s disease (PD) exhibit mild to moderate depression, which is often underdiagnosed. It is unclear whether depression results from having a debilitating disease or reflects a parallel abnormal change in the brain caused by PD pathophysiology.

A Potential New Strategy to Face Dementia

October 8, 2013 - Alzheimer’s disease (AD) affects millions of people worldwide. As a result of an increase in life expectancy, the number of patients with dementia is expected to increase dramatically. Due to the lack of effective treatments that can slow down or reverse the progression of AD, preventive measures to lower the prevalence rate of AD by means of managing potential or actual risk factors is a reasonable clinical strategy. In this respect, identifying treatable factors which are able to promote cognitive deterioration would have important practical implications.

Novel accelerometer-based algorithm detects early signals of Alzheimer’s disease in everyday motion behavior

October 8, 2013 - The projected substantial increase in Alzheimer’s disease due to the higher life expectancy in modern societies is one of the great future challenges of health care systems worldwide. Alzheimer’s disease leads to significant changes in the temporal structure of activities that impair everyday activities. Abnormal motion behavior and degeneration of the sleep-waking cycle are among the most severe behavioral symptoms. An early detection and even a prediction of these behaviors would allow a timely onset of interventions that aim to delay the manifestation or exacerbation of symptoms and reduce the need of institutionalized care.

Changing to the Western diet increases risk of Alzheimer’s disease

September 25, 2013 - In a paper just published electronically in the Journal of Alzheimer’s Disease, dramatic increases in Alzheimer’s disease (AD) in Japan and significant increases in developing countries are linked to changes in national diets.

Transcranial Direct Current Stimulation Improves Sleep in Patients with Post-Polio Syndrome

August 27, 2013 - Of the 15 million people around the world who have survived poliomyelitis, up to 80% report progressive deteriorating strength and endurance many years after infection, a condition known as post-polio syndrome (PPS). Researchers in Italy from the National Hospital for Poliomyelitis, the Policlinico G.B. De Rossi in Verona, and the University of Milan have found that transcranial direct current stimulation (tDCS) for 15 days improved sleep and fatigue symptoms in patients with PPS, suggesting this non-invasive tool may be a new therapeutic option for this condition. Their results are published in Restorative Neurology and Neuroscience.

New Study Supports Intracerebral Injections of Bone Marrow-Derived Stem Cells to Prevent or Reduce Post-Stroke Cognitive Deficits

August 26, 2013 - Cognitive deficits following ischemic stroke are common and debilitating, even in the relatively few patients who are treated expeditiously so that clots are removed or dissolved rapidly and cerebral blood flow restored. A new study in Restorative Neurology and Neuroscience demonstrates that intracerebral injection of bone-marrow-derived mesenchymal stem cells (BSCs) reduces cognitive deficits produced by temporary occlusion of cerebral blood vessels in a rat model of stroke, suggesting that BSCs may offer a new approach for reducing post-stroke cognitive dysfunction.

Antisense Oligoneucleotide Corrects Striatal Transcriptional Abnormalities and Protects Function in HD Mice

August 26, 2013 - Findings from postmortem studies of the brains of Huntington’s Disease (HD) patients suggest that transcriptional dysregulation may be an early step in the pathogenesis of HD before symptoms appear. Other studies report transcriptional alterations in the brains of some mouse models of HD. A new study has found transcriptional changes in mouse striatum which correlate with progressive motor and psychiatric deficits and, most importantly, reports for the first time, that an antisense oligonucleotide (ASO) may be used therapeutically to both correct striatal transcriptional abnormalities and improve motor and behavioral problems. The article is published in the latest issue of the Journal of Huntington’s Disease.

UCLA study suggests iron is at core of Alzheimer’s disease

August 26, 2013 - Alzheimer's disease has proven to be a difficult enemy to defeat. After all, aging is the No. 1 risk factor for the disorder, and there's no stopping that.

Novel Chinese Herbal Medicine JSK Improves Spinal Cord Injury Outcomes in Rats

August 20, 2013 - A new study published in Restorative Neurology and Neuroscience demonstrates that Chinese herbal medicine Ji-Sui-Kang (JSK), given systemically for three weeks after injury in rats, improved locomotor function, reduced tissue damage, and preserved the structure of neural cells compared to control rats. The report also includes data showing that JSK may first act to reduce inflammation and cell apoptosis and death, and boost local oxygen supply while, later on, it appears to restore function and promote tissue regeneration.

Breastfeeding may reduce Alzheimer’s risk

August 8, 2013 - Mothers who breastfeed their children may have a lower risk of developing Alzheimer’s Disease, with longer periods of breastfeeding also lowering the overall risk, a new study suggests.

Exercise May be the Best Medicine for Alzheimer’s Disease, UMD Study Shows

August 7, 2013 - New research out of the University of Maryland School of Public Health shows that exercise may improve cognitive function in those at risk for Alzheimer’s by improving the efficiency of brain activity associated with memory. Memory loss leading to Alzheimer’s disease is one of the greatest fears among older Americans. While some memory loss is normal and to be expected as we age, a diagnosis of mild cognitive impairment, or MCI, signals more substantial memory loss and a greater risk for Alzheimer’s, for which there currently is no cure.

Necrostatin-1 Counteracts Aluminum’s Neurotoxic Effects

August 5, 2013 - Investigators have linked aluminum accumulation in the brain as a possible contributing factor to neurodegenerative disorders such as Alzheimer’s disease. A new study published in Restorative Neurology and Neuroscience sheds light on the mechanism underlying aluminum-induced neuronal cell death and identifies necrostatin-1 as a substance which counteracts several of aluminum’s neurotoxic effects.

Poor dental health may lead to Alzheimer’s, study suggests

August 1, 2013 - People with poor oral hygiene or gum disease may be at a greater risk of developing Alzheimer’s disease, a new...

Higher Education May Be Protective Against MS-Associated Cognitive Deficits

July 3, 2013 - Multiple sclerosis (MS) can lead to severe cognitive impairment as the disease progresses. Researchers in Italy have found that patients with high educational levels show less impairment on a neuropsychological evaluation compared with those with low educational levels. Their results are published in Restorative Neurology and Neuroscience.

New Alzheimer’s research suggests possible cause: the interaction of proteins in the brain

June 26, 2013 - For years, Alzheimer's researchers have focused on two proteins that accumulate in the brains of people with Alzheimer's and may contribute to the disease: plaques made up of the protein amyloid-beta, and tangles of another protein, called tau.

PD-Like Sleep and Motor Problems Observed in α-Synuclein Mutant Mice

June 11, 2013 - The presence of Lewy bodies in nerve cells, formed by intracellular deposits of the protein α-synuclein, is a characteristic pathologic feature of Parkinson’s Disease (PD). In the quest for an animal model of PD that mimics motor and non-motor symptoms of human PD, scientists have developed strains of mice that overexpress α-synuclein. By studying a strain of mice bred to overexpress α-synuclein via the Thy-1 promoter, scientists have found these mice develop many of the age-related progressive motor symptoms of PD and demonstrate changes in sleep and anxiety. Their results are published in the latest issue of Journal of Parkinson’s Disease.

Alzheimer’s Leaves Clues in Blood

June 5, 2013 - Alzheimer researchers in Spain have taken a step closer to finding a blood test to help in the diagnosis of Alzheimer’s disease.

UC Santa Barbara Scientists Discover Cinnamon Compounds’ Potential Ability to Prevent Alzheimer’s

May 29, 2013 - Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important health benefit? The common baking spice might hold the key to delaying the onset of — or warding off — the effects of Alzheimer’s disease.

Traumatic Brain Injury Poses Complex Diagnostic, Management and Treatment Challenges in Older People

May 7, 2013 - Each year more than 1.7 million people in the United States sustain a traumatic brain injury (TBI). The incidence of TBI in older adults poses special diagnostic, management and treatment challenges, say experts in a special collection of papers on TBI in the elderly in NeuroRehabilitation: An Interdisciplinary Journal.

Large Animal Models of Huntington’s Disease Offer New and Promising Research Options

April 23, 2013 - Scientific progress in Huntington’s disease (HD) relies upon the availability of appropriate animal models that enable insights into the disease’s genetics and/or pathophysiology. Large animal models, such as domesticated farm animals, offer some distinct advantages over rodent models, including a larger brain that is amenable to imaging and intracerebral therapy, longer lifespan, and a more human-like neuro-architecture. Three articles in the latest issue of the Journal of Huntington’s Disease discuss the potential benefits of using large animal models in HD research and the implications for the development of gene therapy.

Short-Term Benefits Seen With Repetitive Transcranial Magnetic Stimulation for Focal Hand Dystonia

April 10, 2013 - Repetitive transcranial magnetic stimulation (rTMS) is being increasingly explored as a therapeutic tool for movement disorders associated with deficient inhibition throughout the central nervous system. This includes treatment of focal hand dystonia (FHD), characterized by involuntary movement of the fingers either curling into the palm or extending outward. A new study published in Restorative Neurology and Neuroscience reports short-term changes in behavioral, physiologic, and clinical measures that support further research into the therapeutic potential of rTMS.

Sexuality, Traumatic Brain Injury, and Rehabilitation

April 8, 2013 - Each year more than three million Americans are living with traumatic brain injury (TBI), a condition that is associated with physical, cognitive, and emotional problems that often affect their sexuality, and subsequently their marital stability, identity, and self-esteem. Taking an in-depth look at the impact of TBI on sexuality, an investigative team critically reviews fourteen studies representing a collective study sample of nearly 1,500 patients, partners, spouses, control individuals, and rehabilitation professionals to examine brain injury and sexuality. It is published in NeuroRehabilitation: An International Journal.

Shift of Language Function to Right Hemisphere Impedes Post-Stroke Aphasia Recovery

April 4, 2013 - In a study designed to differentiate why some stroke patients recover from aphasia and others do not, investigators have found that a compensatory reorganization of language function to right hemispheric brain regions bodes poorly for language recovery. Patients who recovered from aphasia showed a return to normal left-hemispheric language activation patterns. These results, which may open up new rehabilitation strategies, are available in the current issue of Restorative Neurology and Neuroscience.

UCLA brain-imaging tool and stroke risk test help identify cognitive decline early

April 4, 2013 - UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of cognitive decline early on in individuals who don't yet show symptoms of dementia.

Shedding Light on Early Parkinson’s Disease Pathology

April 2, 2013 - In a mouse model of early Parkinson’s disease (PD), animals displayed movement deficits, loss of tyrosine-hydroxylase (TH)-positive fibers in the striatum, and astro-gliosis and micro-gliosis in the substantia nigra (SN), without the loss of nigral dopaminergic neurons. These findings, which may cast light on the molecular processes involved in the initial stages of PD, are available in the current issue of Restorative Neurology and Neuroscience.

Probable amnestic MCI people are in the highest risk of conversion to dementia

March 5, 2013 - People with probable amnestic mild cognitive impairment (MCI) have the most and closest risk of conversion to dementia, mainly Alzheimer’s disease (AD), according to a recent research of Fundació ACE, Barcelona Alzheimer Treatment and Research Center ( That is, amnestic MCI subjects without any comorbidity that could explain their cognitive deficits have 8.5 times more risk to convert to dementia than people with non-amnestic MCI caused by cerebrovascular pathology or psycho-affective symptoms. Furthermore, a storage pattern of memory impairment, the multiple domain condition, and the presence of at least one ε4 allele increase the risk of conversion to dementia in MCI subjects.

Novel Herbal Compound Offers Potential to Prevent and Treat Alzheimer’s Disease

February 19, 2013 - Administration of the active compound tetrahydroxystilbene glucoside (TSG) derived from the Chinese herbal medicine Polygonum multiflorum Thunb, reversed both overexpression of α-synuclein, a small protein found in the brain, and its accumulation using a mouse model of Alzheimer’s disease. These results, which may shed light on the neuropathology of AD and open up new avenues of treatment, are available in the current issue of Restorative Neurology and Neuroscience.

Most U.S. neurologists plan to use new brain scan for Alzheimer’s detection

February 14, 2013 - A large majority of the nation's top neurologists say they would use a recently approved amyloid detection brain scan to evaluate their patients for Alzheimer's disease if the scan was paid for by health insurance, according to a survey recently published in the Journal of Alzheimer's Disease.

Vitamin D, omega-3 may help clear amyloid plaques found in Alzheimer’s

February 7, 2013 - A team of academic researchers has pinpointed how vitamin D3 and omega-3 fatty acids may enhance the immune system's ability to clear the brain of amyloid plaques, one of the hallmarks of Alzheimer's disease.

Exercise can slow onset of Alzheimer’s memory loss — scientists identify link

January 28, 2013 - Keeping active can slow down the progression of memory loss in people with Alzheimer’s disease, a study has shown. A team of researchers from The University of Nottingham has identified a stress hormone produced during moderate exercise that may protect the brain from memory changes related to the disease. The work, funded by Research into Ageing (Age UK) and the University and published in the Journal of Alzheimer’s Disease, may also explain why people who are susceptible to stress are at more risk of developing the disease.

Blood-Based Biomarkers May Lead to Earlier Diagnosis of Parkinson’s Disease

January 21, 2013 - Parkinson's disease (PD) is a progressive neurological condition. At present, it is usually diagnosed only when motor features are present. Hence, there is a need to develop objective and measurable biomarkers to improve PD diagnostics during its earlier stage, prior to its motor onset. In this pilot study, researchers identified and tested the first blood-based circulating microRNA (miRNA) biomarkers for PD. Their results are published in the latest issue of Journal of Parkinson’s Disease.

Studies Provide New Insights into Brain-Behavior Relationships

January 16, 2013 - Approximately half a million individuals suffer strokes in the US each year, and about one in five develops some form of post-stroke aphasia, the partial or total loss of the ability to communicate. By comparing different types of aphasia, investigators have been able to gain new insights into the normal cognitive processes underlying language, as well as the potential response to interventions. Their findings are published alongside papers on hemispatial neglect and related disorders in the January, 2013 issue of Behavioural Neurology.

Cell Loss in the Brain Relates to Variations in Individual Symptoms in Huntington’s Disease

January 7, 2013 - Scientists have wrestled to understand why Huntington’s disease, which is caused by a single gene mutation, can produce such variable symptoms. An authoritative review by a group of leading experts summarizes the progress relating cell loss in the striatum and cerebral cortex to symptom profile in Huntington’s disease, suggesting a possible direction for developing targeted therapies. The article is published in the latest issue of the Journal of Huntington’s Disease.

Method developed by VTT targets diagnosis of early Alzheimer’s disease

December 5, 2012 - A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer’s disease currently takes on average 20 months to diagnose in Europe. VTT has shown that the new method could allow as many as half of patients to get a diagnosis approximately a year earlier.

Biomarker Progress Offers Hope for Early Autism Spectrum Disorder Detection

December 4, 2012 - Autism spectrum disorders (ASD) are neurodevelopmental disorders typically characterized by difficulties in social interactions and delayed or abnormal language development. Although ASD reportedly affects 1 in 88 people in the United States, to date there have been no distinctive biomarkers to diagnose the disease. In a special themed issue of Disease Markers, investigators report on the current understanding of ASD genetics and the possibilities of translating genetic research toward biomarker development in ASD.

2013 Neuroscience Neurology Brochure

November 27, 2012 - Download the 2013 Neuroscience Neurology Brochure here.

Controlling Vascular Disease May Be Key to Reducing Prevalence of Alzheimer’s Disease

November 6, 2012 - Over the last 15 years, researchers have found a significant association between vascular diseases such as hypertension, atherosclerosis, diabetes type 2, hyperlipidemia, and heart disease and an increased risk of Alzheimer’s disease. In a special issue of the Journal of Alzheimer’s Disease, leading experts provide a comprehensive overview of the pathological, biochemical, and physiological processes that contribute to Alzheimer’s disease risk and ways that may delay or reverse these age-related abnormalities.

Abnormal Involuntary Eye Movements in the “Lazy Eye” Disease Amblyopia Linked to Changes in Subcortical Regions of the Brain

October 17, 2012 - The neural mechanism underlying amblyopia, also called “lazy eye” is still not completely clear. A new study now reports abnormal eye movements of the lazy eye, which suggests that disturbed functioning of eye movement coordination between both eyes and not primarily the dysfunction of the visual cortex may be a cause of amblyopia (Xue-feng Shi et al.).

New Model to Explain the Role of Dopamine in Immune Regulation Described

October 11, 2012 - Dopamine is a neurotransmitter that is associated with emotions, movement, and the brain’s pleasure and reward system. In the current issue of Advances in Neuroimmune Biology, investigators provide a broad overview of the direct and indirect role of dopamine in modulating the immune system and discuss how recent research has opened up new possibilities for treating diseases such as Parkinson’s and Alzheimer’s disease, schizophrenia, multiple sclerosis or even the autoimmune disorders.

Inaugural Issue International Journal of Developmental Science

October 1, 2012 - IOS Press is delighted to present the official inaugural issue of the International Journal of Developmental Science which includes a collection of short essay reviews about the merits of developmental science from some of the most renowned developmental scientist in the field.

New Diagnostic Biomarkers Offer Ray of Hope for Alzheimer’s Disease

August 30, 2012 - Alzheimer’s disease (AD) is one of the most common brain disorders, with an estimated 35 million people affected worldwide. In the last decade, research has advanced our understanding of how AD affects the brain. However, diagnosis continues to rely primarily on neuropsychological tests which can only detect the disease after clinical symptoms begin. In a supplement to the Journal of Alzheimer’s Disease, investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the disease process is set in motion.

Neural Interface for Hand Prosthesis Can Restore Function in Brain Areas Responsible for Motor Control

August 21, 2012 - Amputation disrupts not only the peripheral nervous system but also central structures of the brain. While the brain is able to adapt and compensate for injury in certain conditions, in amputees the traumatic event prevents adaptive cortical changes. A group of scientists reports adaptive plastic changes in an amputee’s brain following implantation of multielectrode arrays inside peripheral nerves. Their results are available in the current issue of Restorative Neurology and Neuroscience.

Scientists Report Promising New Direction for Cognitive Rehabilitation in the Elderly

August 21, 2012 - Research has found that declines in temporal information processing (TIP), the rate at which auditory information is processed, underlies the progressive loss of function across multiple cognitive systems in the elderly, including new learning, memory, perception, attention, thinking, motor control, problem solving, and concept formation. In a new study, scientists have found that elderly subjects who underwent temporal training improved not only the rate at which they processed auditory information, but also in other cognitive areas. The study is published in the current issue of Restorative Neurology and Neuroscience.

Recovery from Pediatric Brain Injury a Lifelong Process, Experts Say

July 9, 2012 - In the last ten years, a new understanding of pediatric brain injury and recovery has emerged. Professionals now understand that recovery may be a lifelong process for the child’s entire circle of family, friends, and healthcare providers. The latest efforts to advance medical and rehabilitative services to move children from medical care and rehabilitation to community reintegration are discussed by the leading experts in a recently published special issue of NeuroRehabilitation.

Music to My Eyes: Device Converting Images into Music Helps Individuals without Vision Reach for Objects in Space

July 9, 2012 - Sensory substitution devices (SSDs) use sound or touch to help the visually impaired perceive the visual scene surrounding them. The ideal SSD would assist not only in sensing the environment but also in performing daily activities based on this input. For example, accurately reaching for a coffee cup, or shaking a friend’s hand. In a new study, scientists trained blindfolded sighted participants to perform fast and accurate movements using a new SSD, called EyeMusic. Their results are published in the July issue of Restorative Neurology and Neuroscience.

Years before Diagnosis, Quality of Life Declines for Parkinson’s Disease Patients

July 2, 2012 - Growing evidence suggests that Parkinson’s disease (PD) often starts with non-motor symptoms that precede diagnosis by several years. In the first study to examine patterns in the quality of life of Parkinson’ disease patients prior to diagnosis, researchers have documented declines in physical and mental health, pain, and emotional health beginning several years before the onset of the disease and continuing thereafter. Their results are reported in the latest issue of Journal of Parkinson’s Disease.

Electrical Brain Stimulation Can Alleviate Swallowing Disorders after Stroke

July 2, 2012 - After stroke, patients often suffer from dysphagia, a swallowing disorder that results in greater healthcare costs and higher rates of complications such as dehydration, malnutrition, and pneumonia. In a new study published in the July issue of Restorative Neurology and Neuroscience, researchers have found that transcranial direct current stimulation (tDCS), which applies weak electrical currents to the affected area of the brain, can enhance the outcome of swallowing therapy for post-stroke dysphagia.

Well-known Author and Historian Reports on Progress in Huntington’s Therapies

June 26, 2012 - Our understanding of the causes and mechanisms of Huntington’s disease (HD) has grown at a dramatic pace since the discovery of the genetic marker for the disease in 1983. While therapies to treat the disease lag behind these laboratory discoveries, disease altering interventions are moving closer to the clinic. In the inaugural issue of the Journal of Huntington’s Disease Alice Wexler, PhD, an authority on the history of Huntington’s disease, author, and research scholar with the UCLA Center for the Study of Women, recounts important milestones along the journey towards a treatment or cure for the disease.

Sleep Improves Functioning in Parkinson’s Patients, but Reasons Remain Elusive

June 20, 2012 - Some Parkinson’s patients report that their motor function is better upon awakening in the morning, which is contrary to what would be expected after a night without medication. This phenomenon, known as sleep benefit, has been studied but no consistent variables have been found and in the last decade there has been little new research. A new study, published in the June issue of the Journal of Parkinson’s Disease, assesses a large sample of Parkinson’s disease (PD) patients and confirms that some patients experience sleep benefit, both overnight and following afternoon naps, but finds no significant variables between those who do benefit and those who do not.

Tai Chi Increases Brain Size and Benefits Cognition in Randomized Controlled Trial of Chinese Elderly

June 20, 2012 - Scientists from the University of South Florida and Fudan University in Shanghai found increases in brain volume and improvements on tests of memory and thinking in Chinese seniors who practiced Tai Chi three times a week, reports an article published today in the Journal of Alzheimer’s Disease.

Device Implanted in Brain Has Therapeutic Potential for Huntington’s Disease

June 19, 2012 - Studies suggest that neurotrophic factors, which play a role in the development and survival of neurons, have significant therapeutic and restorative potential for neurologic diseases such as Huntington’s disease. However, clinical applications are limited because these proteins cannot easily cross the blood brain barrier, have a short half-life, and cause serious side effects. Now, a group of scientists has successfully treated neurological symptoms in laboratory rats by implanting a device to deliver a genetically engineered neurotrophic factor directly to the brain. They report on their results in the latest issue of Restorative Neurology and Neuroscience.

New Studies Hint at Possible Approaches to Protect Those at Risk for Huntington’s Disease

June 19, 2012 - Two new studies published in the inaugural issue of the Journal of Huntington's Disease hint at possible approaches to protect those at risk for HD.

Link between Metabolic Disorders and Alzheimer’s Disease Examined

June 15, 2012 - No effective treatments are currently available for the prevention or cure of Alzheimer’s disease (AD), the most frequent form of dementia in the elderly. The most recognized risk factors, advancing age and having the apolipoprotein E Ɛ4 gene, cannot be modified or treated. Increasingly, scientists are looking toward other risk factors to identify preventive and therapeutic strategies. Much attention recently has focused on the metabolic syndrome (MetS), with a strong and growing body of research suggesting that metabolic disorders and obesity may play a role in the development of dementia.

Drink coffee to avoid Alzheimer’s Disease: study shows older adults benefit

June 6, 2012 - Research shows drinking coffee can avoid the onset of Alzheimer's Disease in people over 65 years old.

Scientists Reveal Early Diagnostic Clues for Alzheimer’s Disease Using Advanced Brain Imaging Technology

May 3, 2012 - Alzheimer’s disease (AD) is a major neurodegenerative disorder that affects millions of people worldwide. New and accurate techniques for early...

Anders Lönneborg, PhD, Receives 2012 Alzheimer Award

May 2, 2012 - Anders Lönneborg, PhD, has been chosen as the recipient of the 2012 Alzheimer Award presented by the Journal of Alzheimer’s...

Walnuts may boost Memory and Improve Cognitive Function

March 1, 2012 - Do you recall what you ate for breakfast today or dinner last night? According to new research, you may have a better chance remembering if you had included walnuts. Recent findings published in the Journal of Alzheimer’s Disease report walnut consumption in a Mediterranean diet is associated with better memory scores and cognitive function. The results suggest that antioxidants present in walnuts and other Mediterranean dietary pattern may help counteract age-related cognitive decline and reduce the incidence of neurodegenerative diseases, including Alzheimer's disease.

Could hypertension drugs help people with Alzheimer’s?

October 19, 2011 - Within the next 20 years it is expected the number of people with Alzheimer’s disease (AD) will double from its current figure of half a million to one million. A new study has looked at whether certain types of drugs used to treat high blood pressure, also called hypertension, might have beneficial effects in reducing the number of new cases of Alzheimer’s disease each year.

Advances in Brain Imaging Can Expedite Research and Diagnosis in Alzheimer’s Disease

October 11, 2011 - Alzheimer’s disease (AD) is a common problem that is becoming progressively burdensome throughout the world. A new supplement to the Journal of Alzheimer’s Disease, Imaging the Alzheimer Brain, clearly shows that multiple imaging systems are now available to help understand, diagnose, and treat the disease.

Scientists uncover new clues to Alzheimer’s risk gene that affects one in six

September 7, 2011 - UK scientists have uncovered how a known risk gene for Alzheimer’s might play a role in the development of the disease. The study – which was funded by Alzheimer’s Society and Alzheimer’s Research UK – provides an exciting new area of investigation for researchers developing treatments and ultimately a cure for the disease. It is being published in the current issue of the Journal of Alzheimer’s Disease.